Amedeo Smart

Free Medical Literature Service


 

Amedeo

Hypertension

  Free Subscription

Articles published in
J Hypertens
    December 2026
  1. BELLICINI MG
    Hypertension and HFpEF: Left Ventricular Hypertrophy does not imply Heart Failure.
    J Hypertens. 2026;44:2312-2313.
    >> Share

  2. DEVI A, Ullah Z
    Comment on 'Blood pressure phenotypes and hypertension-associated cardiac damage'.
    J Hypertens. 2026;44:2311-2312.
    >> Share

  3. KONAN FA, Milot A, Brisson C, Talbot D, et al
    Psychosocial stressors at work and hypertension incidence: a prospective cohort study of multiple exposures.
    J Hypertens. 2026;44:2248-2257.
    >> Share

  4. CAI A, Heagerty AM, Schlaich MP, Parati G, et al
    Investing in the future of hypertension care: lessons from the 2026 World Hypertension League-Chinese Hypertension League Hypertension Summer School.
    J Hypertens. 2026;44:2193-2196.
    >> Share

  5. SANIDAS E, Thomopoulos C
    Game theory in hypertension management.
    J Hypertens. 2026;44:2189-2192.
    >> Share

  6. KARAGIANNIDIS AG, Iatridi F, Theodorakopoulou MP, Karkamani E, et al
    Nighttime and daytime urine sodium excretion, nighttime and daytime blood pressure and nocturia frequency in patients with chronic kidney disease.
    J Hypertens. 2026;44:2273-2281.
    >> Share

  7. NAUDE D, Smith W, von Kanel R, Wentzel A, et al
    Acute mental stress-induced adrenergic reactivity profiles predict distinct cardiometabolic risk trajectories over three years: the SABPA study.
    J Hypertens. 2026;44:2282-2300.
    >> Share

    November 2026
  8. KALLEHAUGE M, Juhl CB, Glintborg D, Andersen MS, et al
    Circadian blood pressure dipping patterns, hypertension, and cortisol metabolism across the weight spectrum.
    J Hypertens. 2026 Nov 6. doi: 10.1097/HJH.0000000000004484.
    >> Share

  9. SHAH SS, Bhatia R, Chauhan K, Fuller PJ, et al
    Prevalence of low-renin hypertension: a systematic review and meta-analysis.
    J Hypertens. 2026 Nov 6. doi: 10.1097/HJH.0000000000004488.
    >> Share

  10. HAMDAN H, Evans JL, Plantinga LC, Ghazaryan S, et al
    Evaluation of a population health strategy to improve albuminuria detection among primary care patients with hypertension.
    J Hypertens. 2026 Nov 3. doi: 10.1097/HJH.0000000000004459.
    >> Share


  11. Alternative ankle-brachial assessments show no significant added value in predicting mortality of hypertensive patients: Erratum.
    J Hypertens. 2026;44:2093.
    >> Share

  12. CUSPIDI C, Tadic M, Grassi G
    Simplified ambulatory nocturnal blood pressure monitoring for nocturnal hypertension: is it the right way ?
    J Hypertens. 2026;44:2090-2091.
    >> Share

  13. MEMON S, Malik MZ, Azhar A, Mahato RK, et al
    Commentary on pharmacogenomics-guided therapy for hypertension: a randomized trial.
    J Hypertens. 2026;44:2088-2089.
    >> Share

  14. LIU J, Heagerty AM
    Nocturnal hypertension management: when East meets West.
    J Hypertens. 2026;44:1940-1941.
    >> Share

  15. KRINGELAND E, Berggreen E, Bunaes DF, Sulo G, et al
    Sex differences in associations of periodontitis with blood pressure and arterial stiffening: the Hordaland Health Study.
    J Hypertens. 2026;44:1966-1973.
    >> Share

  16. BAGGA A, Ibrahim R, Alasmar R, Pham HN, et al
    Diagnostic recognition of primary aldosteronism in clinical practice.
    J Hypertens. 2026;44:2085-2087.
    >> Share

  17. PUCCI G, Sharman JE, Alcidi R, Perotti EM, et al
    Prognostic significance of invasive central and peripheral blood pressures for cardiovascular events and mortality.
    J Hypertens. 2026;44:2027-2033.
    >> Share

  18. LEPOITTEVIN M, Bauvin P, Benani A, Attias P, et al
    Impact of the new 2024 ESC blood pressure classification in a low-risk cohort: the 70 mmhg diastolic threshold may reduce risk discrimination in primary prevention.
    J Hypertens. 2026;44:2041-2049.
    >> Share

    October 2026
  19. CARDOSO AM, Manica A, Morsch VM, Sevigny J, et al
    Exercise attenuates hypertension-induced renal dysfunction alongside changes in purine metabolism and A2A and P2X7 receptor expression.
    J Hypertens. 2026 Oct 30. doi: 10.1097/HJH.0000000000004479.
    >> Share

  20. KETEN MF, Yilmaz C, Kultursay B, Sengor BG, et al
    Electrocardiographic markers of arrhythmic risk after renal sympathetic denervation in resistant hypertension.
    J Hypertens. 2026 Oct 30. doi: 10.1097/HJH.0000000000004490.
    >> Share

  21. STERGIOU GS, Kario K, Aristizabal D, Beheiry H, et al
    2026 International Society of Hypertension Global Hypertension Practice Guidelines.
    J Hypertens. 2026 Oct 20. doi: 10.1097/HJH.0000000000004451.
    >> Share

  22. LUCERA GM, Sa JM, Fernandes MV, Andrade RAP, et al
    Acute angiotensin type 1 receptor blockade restores intracranial cerebral compliance in renovascular hypertension with high sodium intake.
    J Hypertens. 2026 Oct 20. doi: 10.1097/HJH.0000000000004476.
    >> Share

  23. ZANGO D, Copeland V, Wasserstrum Y, Mansour M, et al
    History of hypertension is associated with improved survival in patients with nonischemic etiology of heart failure and reduced ejection fraction.
    J Hypertens. 2026 Oct 20. doi: 10.1097/HJH.0000000000004475.
    >> Share

  24. ZOCCALI C, Sarnak MJ, Kanbay M, Rotmans JI, et al
    Pulmonary hypertension and right ventricular dysfunction in hemodialysis: an overlooked cardiorenal interface and a target for dialysis prescription.
    J Hypertens. 2026 Oct 20. doi: 10.1097/HJH.0000000000004478.
    >> Share

  25. STERGIOU GS, Menti A, Asmar R, Bilo G, et al
    Update of the practical guide for validation studies of automated cuff blood pressure monitors according to the Universal Standard by the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organiz
    J Hypertens. 2026 Oct 9. doi: 10.1097/HJH.0000000000004448.
    >> Share

  26. THYMIS V, Kyriakoulis KG, Menti A, Theodosiadi A, et al
    Hypertension phenotypes in nondialysis patients with chronic kidney disease: systematic review and meta-analysis.
    J Hypertens. 2026 Oct 9. doi: 10.1097/HJH.0000000000004441.
    >> Share

  27. DE BIASE N, Del Punta L, Moura-Ferreira S, De Schutter S, et al
    Disproportionate systolic blood pressure response relative to oxygen consumption identifies a high-risk haemodynamic phenotype in arterial hypertension.
    J Hypertens. 2026 Oct 9. doi: 10.1097/HJH.0000000000004438.
    >> Share

  28. FAN T, Wang Y, Li L
    Alveolar macrophage heterogeneity in pulmonary hypertension: pathogenic mechanisms and precision intervention.
    J Hypertens. 2026 Oct 6. doi: 10.1097/HJH.0000000000004458.
    >> Share

  29. ZUIN M
    Corrigendum to "Arterial hypertension-attributable mortality in Europe, 2012-2021".
    J Hypertens. 2026;44:1897.
    >> Share

  30. KUHN D, Musey PI Jr, Pollard KA, Parrelli GA, et al
    Emergency department blood pressure elevations frequently occur without documented hypertension diagnosis.
    J Hypertens. 2026;44:1893-1895.
    >> Share

  31. RANDJELOVIC M, Wijkman M, Festin K, Kastbom L, et al
    Blood pressure phenotypes and hypertension-associated cardiac damage.
    J Hypertens. 2026;44:1822-1829.
    >> Share

  32. THEODOSIADI A, Kollias A, Stambolliu E, Ntineri A, et al
    Nighttime blood pressure versus non-dipping for predicting asymptomatic organ damage in young individuals.
    J Hypertens. 2026;44:1791-1798.
    >> Share

  33. STERGIOU GS, Menti A, Asayama K, Kollias A, et al
    Wearable wrist-watch type cuff oscillometric blood pressure monitors: consensus statement by the European Society of Hypertension Working Group on blood pressure monitoring.
    J Hypertens. 2026;44:1721-1731.
    >> Share

  34. DANZENG W, Duoji C, Gele G, Wu G, et al
    Theoretical foundations of bloodletting therapy for primary hypertension in the southern school of Tibetan medicine: insights from Qinghai-Tibet Plateau medical theory.
    J Hypertens. 2026;44:1677-1683.
    >> Share

  35. THEODORAKOPOULOU M, Iatridi F, Theodosiadi A, Hecking M, et al
    Efficacy and safety of selective aldosterone synthase inhibitors for blood pressure reduction in patients with CKD: a meta-analysis of randomized controlled trials.
    J Hypertens. 2026;44:1684-1691.
    >> Share

    September 2026
  36. FIELDS E, Berillo O, Schiffrin EL
    The role of the immune system in hypertension.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004440.
    >> Share

  37. HUANG Y, Zhang J, Xu X, Ma J, et al
    Intravenous antihypertensive administration before endovascular treatment in large vessel occlusion stroke: a pooled observational analysis of data from three randomized controlled trials.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004442.
    >> Share

  38. ANNESI L, Agnoletti D, Angilletta E, Baracchi A, et al
    Maternal macrovascular and microvascular adaptation in healthy pregnancy, gestational diabetes, and hypertensive disorders of pregnancy.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004414.
    >> Share

  39. DAMIANAKI A, Iliakis P, Vakka A, Stambolliu E, et al
    New pharmacologic and interventional horizons in hypertension and nondialysis chronic kidney disease: bridging innovation and clinical translation.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004439.
    >> Share

  40. CARDONA-ALVARADO MI, Lund G, Ramirez-Chavez E, Rodriguez-Rios D, et al
    Serum fatty acid profile and desaturase activity in hypertensive patients with and without metabolic syndrome.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004398.
    >> Share

  41. HONETSCHLAGEROVA Z, Miklovic M, Kikerlova S, Sadowski J, et al
    Kidney-brain neural interaction in cardiorenal syndrome: insights from volume-overloaded spontaneously hypertensive rats with aorto-caval fistula.
    J Hypertens. 2026 Sep 18. doi: 10.1097/HJH.0000000000004450.
    >> Share

  42. JANSSEN E, de Jong JJA, Verburgt E, Ter Telgte A, et al
    Blood-brain barrier disruption in response to blood pressure changes in adults with hypertension: a serial MRI study.
    J Hypertens. 2026 Sep 14. doi: 10.1097/HJH.0000000000004444.
    >> Share

  43. YETKIN E, Atmaca H, Gurbuz DC, Yalta K, et al
    Gray zone of hypertension thresholds values can be overcome by individualized symptom-oriented approaches.
    J Hypertens. 2026;44:1664-1665.
    >> Share

  44. ZUIN M
    Response to the letter: "methodological inconsistencies and nomenclature errors in 'arterial hypertension-attributable mortality in Europe, 2012-2021"'.
    J Hypertens. 2026;44:1660-1662.
    >> Share

  45. CAYUELA A, Cayuela L
    Methodological inconsistencies and nomenclature errors in 'Arterial hypertension-attributable mortality in Europe', 2012-2021.
    J Hypertens. 2026;44:1659-1660.
    >> Share

  46. RAM CVS
    Artificial intelligence and hypertension management: experience the journey but fasten your seatbelt.
    J Hypertens. 2026;44:1499-1501.
    >> Share

  47. ZHANG DY, An DW, Yu YL, Kaleta BP, et al
    Home blood pressure telemonitoring reveals race-specific patterns of target organ damage.
    J Hypertens. 2026;44:1636-1646.
    >> Share

  48. ALYAS JT, Nielsen SF, Buus NH
    Explaining blood pressure reduction heterogeneity in sodium-glucose cotransporter-2 inhibitor trials: a meta-analysis stratified by patient characteristics.
    J Hypertens. 2026;44:1487-1498.
    >> Share

  49. SHANTSILA E, Shantsila A, Sperrin M, Gao Z, et al
    Higher skeletal muscle mass is associated with higher blood pressure and left ventricular mass.
    J Hypertens. 2026;44:1594-1604.
    >> Share

    August 2026
  50. POLITI C, Mobrici M, Testa A, Pizzini P, et al
    Marinobufagenin and left ventricular mass and geometry in patients with essential hypertension.
    J Hypertens. 2026 Aug 31. doi: 10.1097/HJH.0000000000004437.
    >> Share

  51. JONES ESW, Ralapanawa U, Wu P, Brewster LM, et al
    Hypertensive disorders of pregnancy and the risk for hypertension and cardiovascular and kidney disease. International Society of Hypertension position paper, endorsed by the World Hypertension League and European Society of Hypertension.
    J Hypertens. 2026 Aug 31. doi: 10.1097/HJH.0000000000004389.
    >> Share

  52. RIVASI G, Salucci C, D'Ambrosio G, Gori V, et al
    Predictors of long-term all-cause mortality and incident disability in older hypertensive outpatients.
    J Hypertens. 2026 Aug 31. doi: 10.1097/HJH.0000000000004431.
    >> Share

  53. NERI L, Orro A, Paolocci N, Borghi C, et al
    Blood pressure monitoring via wearable devices and artificial intelligence in hypertension detection.
    J Hypertens. 2026 Aug 31. doi: 10.1097/HJH.0000000000004419.
    >> Share

  54. LI J, Zhang Y, Fan F, Yi T, et al
    Blood pressure and homocysteine-lowering effects of the amlodipine/folic acid combination in patients with hypertension and serum homocysteine concentration >/=10 mumol/l (H-type hypertension): a multicenter, randomized, double-blind, parallel-control
    J Hypertens. 2026 Aug 31. doi: 10.1097/HJH.0000000000004420.
    >> Share

  55. DE LA SIERRA A, Staplin N, Ruilope LM
    Prognostic significance of the magnitude of the white-coat effect in hypertension.
    J Hypertens. 2026 Aug 13. doi: 10.1097/HJH.0000000000004416.
    >> Share

  56. HUTTL M, Miklovic M, Skaroupkova P, Vanourkova Z, et al
    Long-term treatment with soluble guanylyl cyclase stimulator BAY41-8543 abolishes malignant hypertension-related mortality and attenuates organ damage: studies in Ren-2 transgenic rats treated with L-NAME.
    J Hypertens. 2026 Aug 13. doi: 10.1097/HJH.0000000000004422.
    >> Share


  57. Erratum: Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of spontaneously hypertensive rats through the Yes-associated protein pathway.
    J Hypertens. 2026;44:1473-1474.
    >> Share

  58. ZENG M, Gnanenthiran SR, Chan DKE, Griffiths R, et al
    Reply to comment: Limited public understanding of the risk factors and complications of hypertension.
    J Hypertens. 2026;44:1471-1472.
    >> Share

  59. ANTAR AS, Sharifi A
    Revisiting public understanding of hypertension: methodological considerations and future directions.
    J Hypertens. 2026;44:1466-1467.
    >> Share

  60. CRUICKSHANK JK
    Commentary on characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht Study.
    J Hypertens. 2026;44:1327-1328.
    >> Share

  61. BOMFIM GF, Ryan MJ, Bonilha L, McCarthy CG, et al
    Hypertension in autoimmune rheumatic diseases: progress made, gaps remain.
    J Hypertens. 2026;44:1325-1326.
    >> Share

  62. ZOCCALI C, Mallamaci F
    Hypertension and skeletal fragility: time to add bone to the target-organ list?
    J Hypertens. 2026;44:1322-1324.
    >> Share

  63. LIU W, Liu J, Liu H, Zhang S, et al
    The correlation between nursing workload and abnormal 24-h ambulatory blood pressure profiles in clinical nurses: a cross-sectional study.
    J Hypertens. 2026;44:1423-1433.
    >> Share

  64. GUIMARAES-NETO VS, Paiva AMG, Bezerra R, Feitosa ADM, et al
    Discrepancies in office blood pressure measurement protocols across international guidelines: "Houston, we've got a problem.".
    J Hypertens. 2026;44:1462-1465.
    >> Share

  65. ZHOU Y, Chen Y, Chen YL, Chan CM, et al
    Exercise-induced changes in blood pressure and pulse rate in relation to cardiac structure and function assessed by a wearable wrist-type oscillometric blood pressure monitor.
    J Hypertens. 2026;44:1415-1422.
    >> Share

    July 2026
  66. CHEN K, Liang Y, Yin T, Lv Y, et al
    Effects of exercise on aerobic capacity in people with prehypertension or hypertension: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004405.
    >> Share

  67. GHERBESI E, Faggiano A, Sala C, Carugo S, et al
    Left ventricular hypertrophy in hypertension: a systematic review and meta-analysis of echocardiographic studies published from 2011 to 2025.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004408.
    >> Share

  68. DOKU A, Kruger R, Asamoah KT, Akumiah FK, et al
    2026 ISH guidelines for the management of hypertension in Africa: the International Society of Hypertension (ISH) African Regional Advisory Group and the Pan African Society of Cardiology (PASCAR).
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004411.
    >> Share

  69. ZHANG MJ, Bo YC, Shi JZ, Xu MD, et al
    The association of cardiovascular health with new-onset pulmonary hypertension and the mediating role of proteomic signatures.
    J Hypertens. 2026 Jul 28. doi: 10.1097/HJH.0000000000004409.
    >> Share

  70. CHANG SN, Lee GW, Chen JJ, Wang CH, et al
    Integrative genomic and transcriptomic analysis of hypertension in a Taiwanese population.
    J Hypertens. 2026 Jul 24. doi: 10.1097/HJH.0000000000004395.
    >> Share

  71. GROBMAN B, Wang FM, Ngige AA, Rajesh S, et al
    Hypertension treatment and risk of cardiovascular disease or mortality across risk equations: results from SPRINT.
    J Hypertens. 2026 Jul 23. doi: 10.1097/HJH.0000000000004397.
    >> Share

  72. SCHWENDINGER F, Wagner J, Hauser C, Fleischlin E, et al
    All eyes on gas exchange: impact of controlled arterial hypertension on cardiopulmonary function and the effects of high-intensity interval training.
    J Hypertens. 2026 Jul 17. doi: 10.1097/HJH.0000000000004394.
    >> Share

  73. URUSKI P, Mikula-Pietrasik J, Tykarski A, Ksiazek K, et al
    Nebivolol treatment improves hypertension-induced endothelial cell dysfunction by reducing TGF-beta1-dependent senescence and normalizing mitochondrial indices.
    J Hypertens. 2026 Jul 3. doi: 10.1097/HJH.0000000000004391.
    >> Share

  74. MEMON S
    Metabolic syndrome and uric acid in pediatric hypertension: implications for early target organ damage risk stratification.
    J Hypertens. 2026;44:1283.
    >> Share

  75. GOVO V, Mateus A, Novela C, Caupers P, et al
    Prevalence of masked hypertension in patients with diabetes: a study in Mozambique.
    J Hypertens. 2026;44:1197-1204.
    >> Share

  76. RUIDER DT, Gomes MFP, Montrezol FT, Antunes HKM, et al
    Pilates training is associated with reduced ambulatory blood pressure and enhanced autonomic reflex responsiveness in women with hypertension.
    J Hypertens. 2026;44:1162-1172.
    >> Share

  77. FLORAS JS
    Baroreflex activation therapy for resistant hypertension: promise present or passed?
    J Hypertens. 2026;44:1120-1122.
    >> Share

  78. ALGHAMDI R, Osman H, Highton PJ, Fahad M, et al
    A literature review of the pharmacokinetic profiles of 20 commonly prescribed antihypertensive medications for use in chemical adherence testing.
    J Hypertens. 2026;44:1109-1115.
    >> Share

  79. FILHO ECA, Cesena FY, Blaas BN, de Faria MMP, et al
    Orthostatic blood pressure transitions: Association with symptoms and frailty.
    J Hypertens. 2026;44:1247-1253.
    >> Share

  80. COLLIER SK, Hadad M, Godwin BC, Peterman JE, et al
    Sex differences in the association between positional blood pressure and mortality.
    J Hypertens. 2026;44:1155-1161.
    >> Share

  81. ANDERSON VA, Kambo K, Bruce-Low S, Galbraith A, et al
    The comparative effectiveness of different exercise training modes on ambulatory blood pressure: a systematic review and network meta-analysis of randomized controlled trials.
    J Hypertens. 2026;44:1087-1096.
    >> Share

  82. ERNST L, Wallbach M, Zander W, Koziolek MJ, et al
    Effect of baroreflex activation therapy on home blood pressure measurements after long-term treatment - a prospective, randomized crossover study.
    J Hypertens. 2026;44:1123-1128.
    >> Share

    June 2026
  83. ALSAQER K, Hashish SA, Kawafha M, Al-Maghaireh D, et al
    Effectiveness of a hybrid model education program for hypertension management: a secondary analysis of healthy community clinic records in Jordan.
    J Hypertens. 2026 Jun 22. doi: 10.1097/HJH.0000000000004361.
    >> Share

  84. BORZESHI EZ, Valdez M, Kindt A, Arshi B, et al
    Pharmacometabolomics of treatment response to antihypertensive drugs: a systematic review.
    J Hypertens. 2026 Jun 22. doi: 10.1097/HJH.0000000000004355.
    >> Share

  85. YILMAZ Y, Celik FB, Atici A, Guvenc TS, et al
    Peripheral endothelial and coronary microvascular responses to lipophilic versus hydrophilic ACE inhibitors in newly diagnosed hypertension.
    J Hypertens. 2026 Jun 18. doi: 10.1097/HJH.0000000000004357.
    >> Share

  86. LIU Q, Liang Y, Sun Y, Gong M, et al
    Diagnostic performance of simplified ambulatory nocturnal blood pressure monitoring for nocturnal hypertension and target organ damage assessment.
    J Hypertens. 2026 Jun 18. doi: 10.1097/HJH.0000000000004378.
    >> Share

  87. ATHANASOPOULOU E, Weber T, Sharman JE, Wassertheurer S, et al
    Novel hypertension phenotypes based on cross-classification of 24-h brachial and aortic SBP.
    J Hypertens. 2026 Jun 16. doi: 10.1097/HJH.0000000000004376.
    >> Share

  88. MORAES MR, Aranha AR, Silva E, Ide BN, et al
    Dose-response effects of isometric wall squats on postexercise hypotension in older women with hypertension.
    J Hypertens. 2026 Jun 16. doi: 10.1097/HJH.0000000000004381.
    >> Share

  89. TABARA Y, Matsumoto T, Murase K, Kawaguchi T, et al
    Association between orthostatic blood pressure change and masked and white coat hypertension: the Nagahama study.
    J Hypertens. 2026 Jun 11. doi: 10.1097/HJH.0000000000004366.
    >> Share

  90. XU T, Xing J, Lin X, Yang Y, et al
    Genus-level oral microbiome composition and Dietary Approaches to Stop Hypertension dietary adherence in relation to hypertension.
    J Hypertens. 2026 Jun 11. doi: 10.1097/HJH.0000000000004377.
    >> Share

  91. JI H, Ma S, Bao W, Li X, et al
    Transcriptomic analysis identifies novel ferroptosis-related biomarkers and therapeutic targets in pulmonary arterial hypertension.
    J Hypertens. 2026 Jun 11. doi: 10.1097/HJH.0000000000004374.
    >> Share

  92. FENG P, Wang B, Liu X, Lv N, et al
    Impact of obstructive sleep apnea-hypopnea syndrome on coronary microcirculation in hypertensive patients.
    J Hypertens. 2026 Jun 11. doi: 10.1097/HJH.0000000000004370.
    >> Share

  93. HADJ YOUCEF L, Jacquin C, Orquevaux P, Rieu P, et al
    Can placental histology reveal preexisting hypertension in patients who develop preeclampsia?
    J Hypertens. 2026 Jun 11. doi: 10.1097/HJH.0000000000004373.
    >> Share

  94. CHI M, Tang J, Wang S, Xiao D, et al
    Retinal vascular features enhance short-term prediction of delivery in hypertensive disorders of pregnancy.
    J Hypertens. 2026 Jun 9. doi: 10.1097/HJH.0000000000004369.
    >> Share

  95. CHU Q, Zhang S, Zhang H, Kong L, et al
    Interpretable deep learning with pharmacogenomics predicts myocardial infarction in angiotensin receptor blocker treated hypertension.
    J Hypertens. 2026;44:1014-1021.
    >> Share

  96. SANTANDER VS, Monesterolo NE, Balach MM, Nigra AD, et al
    Activity of tubulin tyrosine ligase in erythrocytes is affecting arterial blood pressure: effect of tyrosine and no3-tyrosine on hypertension development.
    J Hypertens. 2026;44:970-979.
    >> Share

  97. MANTA E, Fragoulis C, Tsioufis K
    Unmasking genetic predictors of myocardial infarction in arterial hypertension treated with angiotensin receptor blockers via interpretable artificial intelligence.
    J Hypertens. 2026;44:957-958.
    >> Share

  98. VERMEER CJC, Van den Dries CJ, Hollander M, Geersing GJ, et al
    Wrist-type home blood pressure monitoring device improves usability and preserves sleep quality compared with conventional ambulatory monitoring.
    J Hypertens. 2026;44:1032-1040.
    >> Share

  99. LI N, Liang N, Zhang X, Dong Y, et al
    Biological age acceleration in primary aldosteronism: associations with renin, aldosterone, aldosterone-to-renin ratio, and left ventricular mass index.
    J Hypertens. 2026;44:1005-1013.
    >> Share

  100. ISHIKAWA J, Saito Y, Toba A, Fukushima K, et al
    Progression of exaggerated blood pressure variability in annual 24-h ambulatory blood pressure monitoring associated with autonomic dysfunction: a pathological case report.
    J Hypertens. 2026;44:1062-1067.
    >> Share

  101. KAPLAN A, Copeland V, Regev E, Fefer P, et al
    Change in blood pressure following transcatheter aortic valve implantation: predictors and association with prognosis.
    J Hypertens. 2026;44:992-998.
    >> Share

    May 2026
  102. LIU X, Lian Y, Guo W, Li M, et al
    Association of cumulative low-dose occupational ionizing radiation exposure with hypertension and blood pressure: a cross-sectional study of Chinese medical radiologists.
    J Hypertens. 2026 May 26. doi: 10.1097/HJH.0000000000004330.
    >> Share

  103. OHLROGGE AH, Xu X, Goodman A, Jennings G, et al
    Update from the National Hypertension Taskforce of Australia: prevalence, treatment and control rates of hypertension between 2022 and 2024 - implications and future directions.
    J Hypertens. 2026 May 25. doi: 10.1097/HJH.0000000000004358.
    >> Share

  104. GKALIAGKOUSI E, Doumas M, Lazaridis A, de Ciuceis C, et al
    Hypertension in autoimmune rheumatic diseases - a position paper from the ESH working group on small arteries.
    J Hypertens. 2026 May 21. doi: 10.1097/HJH.0000000000004347.
    >> Share

  105. LI D, Zhang F, Sun F, Zhao J, et al
    Association between dietary patterns and sleep duration among hypertensive patients.
    J Hypertens. 2026 May 18. doi: 10.1097/HJH.0000000000004351.
    >> Share

  106. AFOUSI G, Fard A, Sabouri A
    High-intensity interval training is associated with improvements in ambulatory blood pressure, arterial stiffness, and gut-derived metabolites in adults with hypertension.
    J Hypertens. 2026 May 15. doi: 10.1097/HJH.0000000000004337.
    >> Share

  107. SIMEUNOVIC A, Brunborg C, Heier M, Berg TJ, et al
    Increased 24-h blood pressure and arterial stiffness in young adults with childhood-onset type 1 diabetes: the Norwegian Atherosclerosis and Childhood Diabetes study.
    J Hypertens. 2026 May 15. doi: 10.1097/HJH.0000000000004338.
    >> Share

  108. ZHANG H, Liang Z, Hu X, Jin H, et al
    Plasma proteomic profiles reveal proteins and characteristic patterns associated with hypertension: A prospective cohort study.
    J Hypertens. 2026 May 8. doi: 10.1097/HJH.0000000000004327.
    >> Share

  109. OBRYCKI L, Sikorski M, Skoczynski K, Koziej J, et al
    Metabolic syndrome and serum uric acid level in children and adolescents with hypertension.
    J Hypertens. 2026;44:847-857.
    >> Share

  110. ZOU S, Gao S, Juraschek SP, Miller ER 3rd, et al
    Effects of dietary patterns and sodium intake on blood pressure variability: results from the DASH and DASH-sodium trials.
    J Hypertens. 2026;44:763-770.
    >> Share

  111. TORINO C, Mallamaci F, Sarafidis P, Thedorakopoulou M M, et al
    Feasibility of the extended, 48-h ambulatory blood pressure monitoring in hemodialysis patients: a multicenter study.
    J Hypertens. 2026;44:796-801.
    >> Share

  112. CUSPIDI C, Facchetti R, Tadic M, Mancia G, et al
    A 25-year longitudinal study on dipping/nondipping tracking in the general population: the PAMELA study.
    J Hypertens. 2026;44:836-846.
    >> Share

  113. CHUNG J, Rhee MY, Kim KH, Jang JS, et al
    Reassessing home blood pressure thresholds: clinical implications of lowering the diagnostic criteria to 130/80 mmHg.
    J Hypertens. 2026;44:778-786.
    >> Share

    April 2026
  114. GKALIAGKOUSI E, Lazaridis A, de Ciuceis C, Doumas M, et al
    Hypertension in autoimmune rheumatic diseases: a position paper from the European Society of Hypertension working group on small arteries. Part A: pathophysiology, prevalence and cardiovascular risk estimation.
    J Hypertens. 2026 Apr 30. doi: 10.1097/HJH.0000000000004332.
    >> Share

  115. ABDALLA M, Poudel B, Sakhuja S, Fernandez-Sedano B, et al
    Association between high likelihood of obstructive sleep apnea and masked hypertension: findings from the Jackson heart and coronary artery risk development in young adults studies.
    J Hypertens. 2026 Apr 28. doi: 10.1097/HJH.0000000000004314.
    >> Share

  116. HOU X, Chen Y, Wang Q, Sun Y, et al
    Association between the cumulative average triglyceride glucose-BMI and hypertension incidence among the middle-aged and older population: a prospective nationwide cohort study in China.
    J Hypertens. 2026 Apr 28. doi: 10.1097/HJH.0000000000004312.
    >> Share

  117. TEH JW, Comerford G, Surlis G, Curneen J, et al
    Mineralocorticoid receptor antagonists and mortality in hypertension: a systematic review and meta-analysis.
    J Hypertens. 2026 Apr 28. doi: 10.1097/HJH.0000000000004323.
    >> Share

  118. HINNEH T, Ofori-Aning P, Mishra S, Miezah D, et al
    From evidence to implementation: workforce development and team-based care lessons from the WHO Hypertension 2023 & 2025 report.
    J Hypertens. 2026 Apr 28. doi: 10.1097/HJH.0000000000004321.
    >> Share

  119. ODA A, Tanaka K, Kimura H, Saito H, et al
    eGFR slope and risk of cardiovascular, kidney, and mortality outcomes in hypertension: a longitudinal cohort study.
    J Hypertens. 2026 Apr 15. doi: 10.1097/HJH.0000000000004324.
    >> Share

  120. SANTA MARIA M, Espeche W, Barreda M, Minetto J, et al
    Impact of different exercise modalities on blood pressure in patients with nocturnal hypertension.
    J Hypertens. 2026 Apr 15. doi: 10.1097/HJH.0000000000004317.
    >> Share

  121. LEON JST
    Family medicine organizations: missing stakeholders in the 2025 ACC/AHA hypertension guideline.
    J Hypertens. 2026;44:715-716.
    >> Share

  122. BIAGGIONI I
    Targeting sympathetic activation in the treatment of hypertension.
    J Hypertens. 2026;44:581-583.
    >> Share

  123. MAHATARA E, Mohamed F, Teferi H, Tamirisa K, et al
    Strategies to curb the rising burden of hypertension in sub-Saharan Africa: insights from the WHO global hypertension report 2025.
    J Hypertens. 2026;44:575-578.
    >> Share

  124. SERRANO HERRERA I, Byfield RL, Bateman DA, Li L, et al
    Low nephron endowment increases susceptibility to salt-induced elevation of blood pressure in mice.
    J Hypertens. 2026;44:645-653.
    >> Share

    March 2026
  125. PRESTON RA, Caizapanta EV, Afshartous D, Chaparro L, et al
    Acute blood pressure reduction exceeding safety and autoregulatory limits following rapid-acting antihypertensives for hypertensive urgency.
    J Hypertens. 2026 Mar 31. doi: 10.1097/HJH.0000000000004304.
    >> Share

  126. TODUA I, Salem DN
    Overpowered by uncontrolled hypertension: can we win this war?
    J Hypertens. 2026 Mar 31. doi: 10.1097/HJH.0000000000004307.
    >> Share

  127. ANANTH CV, Fields JC, Lee R, Keyes KM, et al
    Contribution of hypertension to recent changes in cardiovascular disease mortality: a population-based study in the United States.
    J Hypertens. 2026 Mar 24. doi: 10.1097/HJH.0000000000004298.
    >> Share

  128. LIU Q, Li N, Han Q, Chen Y, et al
    Prevalence and influencing factors of masked uncontrolled hypertension among Chinese female patients with clinically controlled hypertension.
    J Hypertens. 2026 Mar 24. doi: 10.1097/HJH.0000000000004296.
    >> Share

  129. GASTGIVARS O, Wiklund U, Brunstrom M
    Risk factor heterogeneity across cardiovascular disease outcomes in treatment-eligible hypertensive patients.
    J Hypertens. 2026 Mar 23. doi: 10.1097/HJH.0000000000004301.
    >> Share

  130. MADEDDU P, Cattaneo M, Giuffre M, Laffin LJ, et al
    Endothelial triple-pathway vasorelaxation as an adjunctive strategy in resistant hypertension.
    J Hypertens. 2026 Mar 20. doi: 10.1097/HJH.0000000000004286.
    >> Share

  131. ZHAO W, Wei Y, Pan Y, Wang M, et al
    Initial systolic blood pressure, antihypertensive treatment timing and outcomes in acute ischemic stroke: a subgroup analysis of CATIS-2 trial.
    J Hypertens. 2026 Mar 19. doi: 10.1097/HJH.0000000000004303.
    >> Share

  132. COCA A, Sanchez R, Molina de Salazar DI, Penaherrera E, et al
    2026 Latin American consensus for the management of patients with hypertension and cardio-renal and metabolic disturbances: endorsed by the Latin American Society of Hypertension, the Iberoamerican Hypertension League, and the World Hypertension Leagu
    J Hypertens. 2026 Mar 17. doi: 10.1097/HJH.0000000000004290.
    >> Share

  133. BETAT A, Santos VD, Oliveira CGA, Alflen L, et al
    Does hypercholesterolemia worsen cognitive decline in arterial hypertension? Insights from clinical and experimental studies.
    J Hypertens. 2026 Mar 17. doi: 10.1097/HJH.0000000000004277.
    >> Share

  134. HUNTER-COOPER SD, Rahimi M, Mclean RJC, Gona PN, et al
    Effects of yoga posture and slow deep breathing interventions on ambulatory blood pressure in adults with hypertension.
    J Hypertens. 2026 Mar 16. doi: 10.1097/HJH.0000000000004292.
    >> Share

  135. PARRELLI GA, Musey PI Jr, Kuhn D
    Hypertensive emergency department patients frequently have no existing hypertension diagnosis or antihypertensive medications.
    J Hypertens. 2026 Mar 16. doi: 10.1097/HJH.0000000000004293.
    >> Share

  136. DE LEEUW PW, Mancia G, Palmer CR, Ruilope LM, et al
    Patient-profiled treatment responses in a large hypertension trial: a posthoc analysis of the INSIGHT study.
    J Hypertens. 2026 Mar 12. doi: 10.1097/HJH.0000000000004284.
    >> Share

  137. ANTZA C, Jordan J, McGowan B, Ciudin A, et al
    Treating obesity and heart failure: a how-to-manage guide from the European Association for the Study of obesity and the European Society of Hypertension working group on diabetes and metabolic risk factors.
    J Hypertens. 2026 Mar 10. doi: 10.1097/HJH.0000000000004285.
    >> Share

  138. BELLICINI MG
    The theory of hypertensive heart disease and heart failure: revisiting the evidence and pathophysiology.
    J Hypertens. 2026 Mar 6. doi: 10.1097/HJH.0000000000004283.
    >> Share

  139. PETROSKI-MORAES BC, Ramos IT, Sousa JH, de Queiroz MCT, et al
    Estrogen treatment restores perivascular adipose tissue -mediated anticontractile effect via NOX4-dependent hydrogen peroxide signaling in ovariectomized hypertensive rats.
    J Hypertens. 2026 Mar 4. doi: 10.1097/HJH.0000000000004279.
    >> Share

  140. JIANG Z, Zhai C, He C, Shen L, et al
    Effects and mechanisms of probiotics supplement on hypertension.
    J Hypertens. 2026 Mar 3. doi: 10.1097/HJH.0000000000004258.
    >> Share

  141. KORACEVIC G, Stojanovic M
    Treatment of hypertensive urgencies should be intravenous when symptoms are severe.
    J Hypertens. 2026;44:530.
    >> Share

  142. UEDA K, Yeerbolati A, Liang L, Ogura S, et al
    The nondipping blood pressure pattern induced by chronic intermittent hypoxia and its renal mechanism.
    J Hypertens. 2026;44:425-432.
    >> Share

  143. WANG K, Kroon AA, de Galan BE, Berendschot TTJM, et al
    Associations of blood pressure with retinal arteriolar narrowing and urinary albumin excretion are modified by prediabetes: the Maastricht study.
    J Hypertens. 2026;44:461-469.
    >> Share

  144. WANG S, Wu D, Yang G, Shi S, et al
    Association of blood pressure levels in the nonhypertensive range with mortality among people without traditional risk factors.
    J Hypertens. 2026;44:479-488.
    >> Share

    February 2026
  145. YU M, Pan M, Huang B, Fan J, et al
    Pharmacogenomics-guided personalized therapy for hypertension: a multicenter randomized trial.
    J Hypertens. 2026 Feb 26. doi: 10.1097/HJH.0000000000004269.
    >> Share

  146. ZHENG D, Guo Y
    Targeting the Hippo pathway in pulmonary arterial hypertension: emerging pharmacological strategies.
    J Hypertens. 2026 Feb 26. doi: 10.1097/HJH.0000000000004257.
    >> Share

  147. ZHOU E, Zhao H, Yu Y, Liu J, et al
    Combined exposure of cold and hypoxia: a driver for hypertension and the underlying role of the microbiota-gut-brain axis.
    J Hypertens. 2026 Feb 26. doi: 10.1097/HJH.0000000000004281.
    >> Share

  148. HONG S, Jin Y, Li Y, Liu D, et al
    PINK1/Parkin-mediated mitophagy is involved in calcium-sensing receptor-induced cardiac damage and apoptosis in spontaneously hypertensive rats.
    J Hypertens. 2026 Feb 20. doi: 10.1097/HJH.0000000000004273.
    >> Share

  149. KOSTINIUK D, Blankenstein A, Rajic S, Ciantar J, et al
    Prognostic potential of circulatory miR-19a-3p, miR-19b-3p, and miR-329-3p for future hypertension diagnosis.
    J Hypertens. 2026 Feb 19. doi: 10.1097/HJH.0000000000004272.
    >> Share

  150. SETJIADI D, Delles C, Kroon AA, Ressink K, et al
    Characterization of participants with a disproportionate degree of hypertension-mediated organ damage: the Maastricht study.
    J Hypertens. 2026 Feb 16. doi: 10.1097/HJH.0000000000004265.
    >> Share

  151. ZHOU J, Zeng Z, Huang Y, Guo C, et al
    Association of lean body mass and fat mass with peripheral arterial disease events in hypertensive patients.
    J Hypertens. 2026 Feb 11. doi: 10.1097/HJH.0000000000004261.
    >> Share

  152. MIAH B, Marianne Geleijnse JM, Grobbee DE, van der Schouw YT, et al
    Dietary modification of blood pressure-lowering effects of antihypertensive drugs - a scoping review.
    J Hypertens. 2026 Feb 11. doi: 10.1097/HJH.0000000000004247.
    >> Share

  153. IKRAM J, Ali A, Huma S, Shah SW, et al
    Intensive versus routine blood pressure control in patients with type 2 diabetes: a meta-analysis and trial sequential analysis.
    J Hypertens. 2026 Feb 10. doi: 10.1097/HJH.0000000000004267.
    >> Share

  154. FLYNN JT, Kruger R, Brady TM, Chanchlani R, et al
    Practical approach to evaluate and manage hypertension in youth: an International Society of Hypertension position paper.
    J Hypertens. 2026 Feb 7. doi: 10.1097/HJH.0000000000004238.
    >> Share

  155. FRAGOULIS C, Maloberti A, Boulestreau R, De Backer T, et al
    Gaps between guidelines and practice in hypertensive urgencies and emergencies: data from a multinational European registry in ESH excellence centres.
    J Hypertens. 2026 Feb 5. doi: 10.1097/HJH.0000000000004231.
    >> Share

  156. ELBAHLOUL MA, Ali AHG, Al-Shammari AS, Labeeb EE, et al
    Aldosterone synthase inhibitors for resistant or uncontrolled hypertension: a network meta-analysis of randomized clinical trials.
    J Hypertens. 2026 Feb 3. doi: 10.1097/HJH.0000000000004264.
    >> Share

  157. JIN L, Li Z, Li X, Wang X, et al
    Interaction between white coat effect and hypertension on arterial stiffness.
    J Hypertens. 2026 Feb 2. doi: 10.1097/HJH.0000000000004224.
    >> Share

  158. BADHWAR S, Orter S, Mayer CC, Hametner B, et al
    Wave reflections in fibromuscular dysplasia provides insights into the vascular pathophysiology.
    J Hypertens. 2026;44:313-320.
    >> Share

  159. HAMEED MA, Elsadig M, Ahmad S, Haque MS, et al
    Factors associated with treatment-resistant hypertension: results of a prospective observational study.
    J Hypertens. 2026;44:279-287.
    >> Share

  160. OSCULLO G, Gomez-Olivas JD, Sanchez de la Torre M, Gozal D, et al
    The hidden relationship between hypertensive crisis and obstructive sleep apnea.
    J Hypertens. 2026;44:263-265.
    >> Share

  161. BUFFOLO F, Votta S, Goi J, Burrello J, et al
    Screening of obstructive sleep apnea in patients with hypertension: review of the literature and results of an Italian survey.
    J Hypertens. 2026;44:233-242.
    >> Share

  162. SHIRVANI P, Cheraghi L, Shokri S, Amiri P, et al
    The association between triglyceride-glucose index and emotional states in adults with different blood pressure status: a cross-sectional study.
    J Hypertens. 2026;44:329-336.
    >> Share

    January 2026
  163. KOLOSSVARY E, Ferenci T, Jarai Z, Farkas K, et al
    Alternative ankle-brachial assessments show no significant added value in predicting mortality of hypertensive patients.
    J Hypertens. 2026 Jan 30. doi: 10.1097/HJH.0000000000004255.
    >> Share

  164. YEO LF, Palmu J, Havulinna AS, Parnanen K, et al
    Prospective association between the gut microbiome and incident hypertension: a 20-year cohort study.
    J Hypertens. 2026 Jan 30. doi: 10.1097/HJH.0000000000004254.
    >> Share

  165. LOPES J, Dalton-Alves F, Lopes S, Costa EC, et al
    The impact of exercise on resistant hypertension: what do we know in 2025?
    J Hypertens. 2026 Jan 23. doi: 10.1097/HJH.0000000000004242.
    >> Share

  166. SILEIKIENE V, Perone F, Badariene J, Sestokaite E, et al
    Prevalence and cardiometabolic risk of suspected and untreated hypertension in middle-aged Lithuanian men: insights from a cardiovascular disease prevention programme.
    J Hypertens. 2026 Jan 20. doi: 10.1097/HJH.0000000000004241.
    >> Share

  167. ZENG M, Gnanenthiran SR, Chan DKE, Griffiths R, et al
    Limited public understanding of the risk factors and complications of hypertension.
    J Hypertens. 2026 Jan 12. doi: 10.1097/HJH.0000000000004233.
    >> Share

  168. ZUO X, Zhang X, Ye R, Sun L, et al
    Chronic plateau exposure attenuates antihypertensive efficacy in highlanders: insights from the OMAN trial.
    J Hypertens. 2026 Jan 9. doi: 10.1097/HJH.0000000000004226.
    >> Share

  169. TOCCI G, Nardoianni G, Citoni B, Pala B, et al
    Analysis of office and out-of-office blood pressure levels in adult outpatients with hypertensive urgency: a cross-sectional, retrospective study in a hypertension excellence center.
    J Hypertens. 2026 Jan 6. doi: 10.1097/HJH.0000000000004236.
    >> Share

  170. SWIFT PA, Arnold A, Heagerty A, McNally R, et al
    Setting the UK research priorities for hypertension using a modified Delphi approach: a British and Irish Hypertension Society Initiative with Support from the British Heart Foundation Clinical Research Collaborative.
    J Hypertens. 2026 Jan 6. doi: 10.1097/HJH.0000000000004223.
    >> Share

  171. BORGHI F, Jiang Y, Gnudi L
    The expanding role of Nogo-B in hypertension: linking kidney physiology, endothelial function and inflammation.
    J Hypertens. 2026 Jan 6. doi: 10.1097/HJH.0000000000004239.
    >> Share

  172. ASTAN R
    Gut microbiome-metabolome interplay in nondipper hypertension: pathophysiological insights and clinical perspectives.
    J Hypertens. 2026;44:231-232.
    >> Share

  173. OZBEK DA, Altun B
    Reply to correspondence 'Gut microbiome-metabolome interplay in nondipper hypertension: pathophysiological insights and clinical perspectives'.
    J Hypertens. 2026;44:231.
    >> Share

  174. ZANUZZI MG, Hiremath S, Romero CA, Wynne BM, et al
    Arterial hypertension-attributable mortality in Europe: implications for the Americas.
    J Hypertens. 2026;44:60-61.
    >> Share

  175. PRIZAO VM, Morais BAAH, de Souza MM, Mendes BX, et al
    Impact of intensive versus standard blood pressure control on cardiovascular events in hypertensive patients: a meta-analysis of randomized controlled trials.
    J Hypertens. 2026;44:49-55.
    >> Share

  176. NOLDE JM, Rau A, Kellner E, Urbach H, et al
    Central autonomic nervous tract integrity of the brain is linked to blood pressure.
    J Hypertens. 2026;44:211-222.
    >> Share

  177. LU HZ, Jiang TM, Chen ST, Khoo HE, et al
    Modulation of blood pressure in pregnant rats through probiotic-fermented buffalo milk, propionate-producing bacteria, and the phenylalanine metabolic pathway.
    J Hypertens. 2026;44:168-179.
    >> Share

  178. RENNA NF, Ramirez EI, Arrupe MF, Ramirez JM, et al
    Ambulatory blood pressure monitoring strengthens the cardiovascular signal of GLP-1RA: a meta-analysis of blood pressure and weight mediation.
    J Hypertens. 2026;44:123-129.
    >> Share

  179. TABARA Y, Kushida O, Ozaki E, Kuriyama N, et al
    Effects of room temperature on home morning, evening, and sleep blood pressure: the Shizuoka study.
    J Hypertens. 2026;44:109-115.
    >> Share

  180. VIGNATI C, Mattavelli I, Salvioni E, Mapelli M, et al
    Blood pressure before high altitude exposure: are all individuals healthy with controlled arterial blood pressure?
    J Hypertens. 2026;44:116-122.
    >> Share

    December 2025
  181. JELAKOVIC B, Marinovic Glavic M, Belancic A, Bilobrk M, et al
    Determinants of arterial hypertension in Croatian cohort of general adults: EHUH 2 study.
    J Hypertens. 2025 Dec 18. doi: 10.1097/HJH.0000000000004214.
    >> Share

  182. GILL E, Jin X, Fernandez C, Urbina EM, et al
    Association of hypertension disorders of pregnancy and left ventricular remodeling after 15 years follow-up: findings from the Bogalusa Heart Study.
    J Hypertens. 2025 Dec 18. doi: 10.1097/HJH.0000000000004216.
    >> Share

  183. SHECAIRA TP, Araujo AA, Dutra MRH, Ferreira MJ, et al
    Exercise training plus enalapril treatment in male hypertensive rats: beneficial effects on the blood pressure variability and kidneys.
    J Hypertens. 2025 Dec 10. doi: 10.1097/HJH.0000000000004220.
    >> Share

  184. BUCCI T, Lip GYH
    Reply: risk estimation following hypertensive crises.
    J Hypertens. 2025;43:2094.
    >> Share

  185. MEMON ME, Aun SM
    Letter to the editor: limitations in assessing long term risks after hypertensive emergencies.
    J Hypertens. 2025;43:2092.
    >> Share

  186. ATKINS ER, Pikkemaat M, Rodgers A, Schutte AE, et al
    Reply to comment: Treating hypertension with single pill combinations: a simple strategy to save costs for the patients and payers.
    J Hypertens. 2025;43:2091.
    >> Share

  187. STOUTENBURG EG, Long DL, Plante TB
    Considerations on conducting observational research of thromboinflammation and incident hypertension.
    J Hypertens. 2025;43:2090.
    >> Share

  188. PANG G, Wang L
    From cost savings to clinical benefits: thoughts on economic evaluation of single pill combinations in hypertension.
    J Hypertens. 2025;43:2088-2089.
    >> Share

  189. DENG B, Liu W
    Advancing understanding of racial disparities in hypertension: does Factor IX illuminate or confound?
    J Hypertens. 2025;43:2086-2087.
    >> Share

  190. ROSTAMIAN S, Kaura A, Ariti C, Gupta A, et al
    The impact of blood pressure variability on cardiovascular and renal outcomes in patients with and without diabetes: insights from the Anglo-Scandinavian Cardiac Outcomes Trial.
    J Hypertens. 2025;43:2033-2041.
    >> Share

  191. CAI A, Cheng Q, Zhou D, Feng X, et al
    Risk reclassification and cost-effectiveness of echocardiography for cardiovascular primary prevention in hypertension in China.
    J Hypertens. 2025;43:1999-2007.
    >> Share

  192. ANTZA C, Anyfanti P, Kotoulas SC, Kotsis V, et al
    Diagnostic accuracy of blood pressure measurement methods for hypertension screening in obesity: does one fit all?
    J Hypertens. 2025;43:1991-1998.
    >> Share

  193. LIU C, Wang J, Chi J, Dong Y, et al
    Inhibition of calcium-sensitive receptors ameliorates myocardial fibrosis, in Dahl salt-sensitive rats.
    J Hypertens. 2025;43:1972-1983.
    >> Share

  194. JIANG Q, Ji G, Huang P, Huang X, et al
    Trend in hypertension prevalence, awareness, treatment, and control rates among adult residents in Guangdong province, southern China, 2002~2022.
    J Hypertens. 2025;43:1953-1962.
    >> Share

  195. PASDAR Z, Chandanani M, Dhillon N, Carter B, et al
    Hypertensive disorders of pregnancy increase the risk of future ophthalmic disorders: a systematic review and meta-analysis.
    J Hypertens. 2025;43:1903-1911.
    >> Share

  196. ZHANG Y, Tian P, Zeng F, Huang B, et al
    Computed tomography-guided ozone neurolysis lowers blood pressure.
    J Hypertens. 2025;43:2079-2085.
    >> Share

  197. ROCHE-GOMEZ A, Blazquez Gomez CJ, Licero Villanueva A, Espino Hernandez M, et al
    Novel homozygous pathogenic variant in HSD11B2 as a cause of apparent mineralocorticoid excess.
    J Hypertens. 2025;43:2072-2074.
    >> Share

  198. BEZERRA R, Feitosa ADM, Guimaraes-Neto VS, Barbosa R, et al
    Achieving blood pressure control with monotherapy: real-world evidence from office and home blood pressure measurements.
    J Hypertens. 2025;43:2075-2078.
    >> Share

  199. MANDAL AK, Rana T, Shrestha S, Mat Hassan MK, et al
    Effectiveness of aerobic exercise in reducing blood pressure among obese adults: systematic review and meta-analysis.
    J Hypertens. 2025;43:1923-1936.
    >> Share

    November 2025
  200. SHI Y, Zhang M, Miao H, Feng Y, et al
    Association between dietary index for gut microbiota and hypertension: a cross-sectional NHANES-based study.
    J Hypertens. 2025 Nov 28. doi: 10.1097/HJH.0000000000004209.
    >> Share

  201. BANJI D, Banji OJF
    Pharmacogenomic insights into angiotensin converting enzyme inhibitors and calcium channel blockers for personalized hypertension treatment.
    J Hypertens. 2025 Nov 28. doi: 10.1097/HJH.0000000000004212.
    >> Share

  202. VEIGA AC, Silva-Aguiar RP, Campos RR, Bergamaschi CT, et al
    Proteinuria and renal function in hypertension: a role for the renal nerves.
    J Hypertens. 2025 Nov 12. doi: 10.1097/HJH.0000000000004201.
    >> Share

  203. XU X, Land MA, James S, Chow C, et al
    Potassium-enriched salt for patients with hypertension: a Hypertension Australia and National Hypertension Taskforce of Australia Position Statement.
    J Hypertens. 2025 Nov 11. doi: 10.1097/HJH.0000000000004199.
    >> Share

  204. HABIBDOUST A, Zuo H, Koopman RJ, Gupta A, et al
    Target trial emulation in hypertension research: a scoping review of current applications and methodological practices.
    J Hypertens. 2025 Nov 11. doi: 10.1097/HJH.0000000000004188.
    >> Share

  205. QIU CW, Mao LS, Mao JS, Wang W, et al
    Impact of intensive versus higher blood pressure control on cerebral blood flow in hypertension: a systematic review and meta-analysis.
    J Hypertens. 2025 Nov 4. doi: 10.1097/HJH.0000000000004178.
    >> Share

  206. RIPEAU DB, Scaglia PA, Azcoiti ME, Ropelato MG, et al
    Critical role of accurate diagnosis in Liddle's syndrome: a case report and literature review highlighting the importance of genetic testing, a rigorous diagnostic algorithm and early intervention in preventing cardiovascular and renal complications.
    J Hypertens. 2025;43:1889-1893.
    >> Share

  207. JEEMON P, Athira T, Lekha TR, Ismail S, et al
    Family-based interventions for optimal blood pressure outcomes in adults: a cluster randomised controlled trial in India.
    J Hypertens. 2025;43:1871-1877.
    >> Share

  208. STAMOU E, Iliakis P, Konstantinidis D, Manta E, et al
    Association of blood pressure variability and incidence of stroke: a systematic review and meta-analysis.
    J Hypertens. 2025;43:1764-1772.
    >> Share

  209. ZEIJEN VJM, Tilly MJ, Saville KA, Stricker BHC, et al
    Long-term safety and efficacy of renal sympathetic denervation in comparison to a population-based cohort: a propensity-matching approach.
    J Hypertens. 2025;43:1832-1840.
    >> Share

  210. ROSE F, Stevens RS, Morton KS, Yardley L, et al
    How often should self-monitoring of blood pressure be repeated? A secondary analysis of data from two randomized controlled trials.
    J Hypertens. 2025;43:1863-1870.
    >> Share

  211. FUJIWARA T, Hoshide S, Kario K
    Association between home blood pressure control status and cardiovascular prognosis in participants with left ventricular hypertrophy: the J-HOP study.
    J Hypertens. 2025;43:1793-1801.
    >> Share

    October 2025
  212. VAN DER STAM AH, Gagaouzova BS, Kerkhof FI, van Rossum IA, et al
    Haemodynamic determinants of supine hypertension in patients with classical orthostatic hypotension.
    J Hypertens. 2025 Oct 30. doi: 10.1097/HJH.0000000000004194.
    >> Share

  213. RACIOPPI MF, Pons L, Fantinelli J, Diaz RG, et al
    TRPV4 channels mediate exacerbated response to mechanical cues in spontaneously hypertensive rats.
    J Hypertens. 2025 Oct 30. doi: 10.1097/HJH.0000000000004192.
    >> Share

  214. LV Q, Chen C, Lin L, Zhao X, et al
    Efficacy and safety of clevidipine emulsion injection compared with nicardipine in patients with hypertensive emergencies: a randomized, single-blind, positive-parallel-controlled, phase III clinical trial.
    J Hypertens. 2025 Oct 24. doi: 10.1097/HJH.0000000000004180.
    >> Share

  215. TSIOUFIS K, Soulaidopoulos S, Konstantinidis D, Dimitriadis K, et al
    Long-term effects of renal denervation on hypertension management: insights from an ESH center of excellence and a meta-analysis of current evidence.
    J Hypertens. 2025 Oct 23. doi: 10.1097/HJH.0000000000004184.
    >> Share

  216. KEKK Z, Takacs J, Koller A, Torzsa P, et al
    The association between estimated pulse wave velocity and masked hypertension: results from the Hungarian ambulatory blood pressure monitoring registry.
    J Hypertens. 2025 Oct 15. doi: 10.1097/HJH.0000000000004187.
    >> Share

  217. SCHLAICH MP, Weber MA, Flack JM, Danaietash P, et al
    Effects of aprocitentan on prognostically relevant ambulatory blood pressure-derived variables in resistant hypertension.
    J Hypertens. 2025 Oct 2. doi: 10.1097/HJH.0000000000004174.
    >> Share

  218. PALATINI P, Admant L, Gautier S, Labat C, et al
    Association of orthostatic hypertension identified according to different definitions with cardiovascular disease. The PARTAGE study.
    J Hypertens. 2025 Oct 2. doi: 10.1097/HJH.0000000000004177.
    >> Share

  219. HASTINGS E, Greenstein AS
    Exploring sex differences in the association between cerebral small vessel disease, hypertension and cognitive decline.
    J Hypertens. 2025;43:1617-1618.
    >> Share

  220. WAKEHAM DJ, De Oliveira-Gomes D, Howrey MM, Bagga JS, et al
    Exercise blood pressure in adults with high-risk left ventricular hypertrophy: the importance of normalizing blood pressure to oxygen uptake.
    J Hypertens. 2025;43:1650-1657.
    >> Share

    September 2025
  221. D'ELIA L, Rendina D, Iacone R, Russo O, et al
    Triglyceride-glucose index, HOmeostatic Model Assessment index, and new-onset hypertension in middle-aged men.
    J Hypertens. 2025 Sep 25. doi: 10.1097/HJH.0000000000004162.
    >> Share

  222. AN Y, Jin X, Guan X, Liu Y, et al
    Finerenone improves ventricular remodeling and cardiac function in hypertensive rats via IRE1 modulation of XBP1 and TRAF2.
    J Hypertens. 2025 Sep 25. doi: 10.1097/HJH.0000000000004167.
    >> Share

  223. OSCULLO G, Pengo MF, Gomez-Olivas JD, Lombardi C, et al
    Refractory hypertension and obstructive sleep apnea.
    J Hypertens. 2025 Sep 18. doi: 10.1097/HJH.0000000000004166.
    >> Share

  224. SUM SK, Ou YY, Wang YC, Chen TP, et al
    Optimizing blood pressure control in multimorbid hypertensive patients: insights from a real-world taiwanese cohort.
    J Hypertens. 2025 Sep 18. doi: 10.1097/HJH.0000000000004156.
    >> Share

  225. TOCCI G, Nardoianni G, Pala B, Citoni B, et al
    Reclassification of patients with normal blood pressure levels after 2024 European society of cardiology guidelines on hypertension.
    J Hypertens. 2025 Sep 15. doi: 10.1097/HJH.0000000000004140.
    >> Share

  226. CARNAGARIN R, Frost S, Martin E, Nolde JM, et al
    Retinal capillary rarefaction is associated with the systemic immune-inflammatory index in patients with hypertension.
    J Hypertens. 2025 Sep 15. doi: 10.1097/HJH.0000000000004151.
    >> Share

  227. ARISTIZABAL-OCAMPO D, Alvarez-Montoya D, Madrid-Munoz C, Fernandez-Ruiz R, et al
    Circulatory phenotypes in hypertension identified by 24-h ambulatory blood pressure monitoring.
    J Hypertens. 2025 Sep 15. doi: 10.1097/HJH.0000000000004149.
    >> Share

  228. VARRI EKH, Tietavainen J, Suojanen LJ, Choudhary MK, et al
    Higher systemic vascular resistance in individuals with a family history of hypertension.
    J Hypertens. 2025 Sep 15. doi: 10.1097/HJH.0000000000004133.
    >> Share

  229. MUTHU SS, Sukumar S, Kadavigere R, K N S, et al
    Arterial spin labeling MRI in assessing cerebral blood flow changes due to hypertension: a systematic review.
    J Hypertens. 2025 Sep 15. doi: 10.1097/HJH.0000000000004150.
    >> Share

  230. ZUIN M, Mazza A, Maloberti A, Tognola C, et al
    Arterial hypertension-attributable mortality in Europe, 2012-2021.
    J Hypertens. 2025 Sep 8. doi: 10.1097/HJH.0000000000004148.
    >> Share

  231. LAMTI F, Trabelsi I, Dhaoui R, Hajji E, et al
    Efficacy of olive leaf extracts in controlling blood pressure in hypertensive patients: a double-blind randomized clinical trial.
    J Hypertens. 2025 Sep 4. doi: 10.1097/HJH.0000000000004141.
    >> Share

  232. WU W, Huang GL, Cui J
    Causal role of the gut microbiota in pulmonary arterial hypertension: insights from Mendelian randomization.
    J Hypertens. 2025;43:1602.
    >> Share

  233. CAMPESE VM
    Goal blood pressure in hypertension: the game of numbers. A perspective.
    J Hypertens. 2025;43:1475-1477.
    >> Share

  234. BELLICINI MG
    Hypertension doesn't cause heart failure. Rethinking heart failure with preserved ejection fraction and hypertensive heart disease.
    J Hypertens. 2025;43:1473-1474.
    >> Share

  235. REDDY M, Li J, Pajewski NM, Gaussoin SA, et al
    Cerebral small vessel disease and effects of intensive versus standard blood pressure treatment on cardiovascular outcomes and adverse events.
    J Hypertens. 2025;43:1582-1588.
    >> Share

  236. OZBEK DA, Koc NS, Inal N, Kablan SE, et al
    Interplay of gut microbiome and metabolome in various blood pressure phenotypes based on ambulatory BP monitoring reveal new insights in nondipper patients.
    J Hypertens. 2025;43:1539-1553.
    >> Share

  237. LIDANI KCF, Tomar S, Mousavi H, Buscaglia R, et al
    Genome-wide association study of angiotensinogen levels and key single nucleotide polymorphism associations with blood pressure.
    J Hypertens. 2025;43:1500-1509.
    >> Share

  238. RIM D, Dawood T, Fatouleh R, McCarthy B, et al
    Regional structural differences in the brain related to high blood pressure.
    J Hypertens. 2025;43:1570-1581.
    >> Share

  239. IACOVELLI F, Salemme L, Tritto R, Cicco S, et al
    Combined percutaneous renal artery denervation and angioplasty: still too early to consider them complementary?
    J Hypertens. 2025;43:1598-1601.
    >> Share

    August 2025
  240. BAO K, Bao D, Huang Z, Gu W, et al
    Associations of insulin resistance surrogate with resistant hypertension and the severity of hypertension in the chronic kidney disease population.
    J Hypertens. 2025 Aug 21. doi: 10.1097/HJH.0000000000004118.
    >> Share

  241. PREJBISZ A, Dobrowolski P, Bozek G, Kon B, et al
    Patterns of prescription of antihypertensive medications in Poland: a one-year assessment of initiation and persistence of therapy in a nationwide population cohort.
    J Hypertens. 2025 Aug 20. doi: 10.1097/HJH.0000000000004111.
    >> Share

  242. XU R, Wang H, Wei Y, Jiang T, et al
    Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of spontaneously hypertensive rats through the Yes-associated protein pathway.
    J Hypertens. 2025 Aug 12. doi: 10.1097/HJH.0000000000004120.
    >> Share

  243. NARDIN M, Agabiti Rosei C, Rossini C, Bertacchini F, et al
    Potential role of the spleen in the development of arterial hypertension in humans.
    J Hypertens. 2025 Aug 8. doi: 10.1097/HJH.0000000000004115.
    >> Share

  244. BUCCI T, Lam SHM, Argyris AA, Beevers DG, et al
    Long-term risk of adverse events in patients discharged alive after hospitalization for hypertensive crisis.
    J Hypertens. 2025 Aug 7. doi: 10.1097/HJH.0000000000004113.
    >> Share

  245. ZHANG X, Bi W, Ma C, Li K, et al
    Malignant hypertension as a presentation of complement-mediated thrombotic microangiopathy: case series report.
    J Hypertens. 2025 Aug 7. doi: 10.1097/HJH.0000000000004116.
    >> Share

  246. MALAN N, Norton GR, Libhaber CD, Peterson V, et al
    Marked increases in systemic blood flow in resistant or refractory hypertensives of African ancestry in Africa.
    J Hypertens. 2025 Aug 4. doi: 10.1097/HJH.0000000000004114.
    >> Share

  247. LI S, Wang B, Xing J, Li X, et al
    Neuroinflammation and hypertensive cardiac hypertrophy: mechanisms, pathways, and therapeutic perspectives.
    J Hypertens. 2025 Aug 4. doi: 10.1097/HJH.0000000000004108.
    >> Share

  248. OIKONOMOPOULOU I, Kourti O, Zografou A, Paparidou R, et al
    Predictors of hypertension after preeclampsia: the enigma remains alive.
    J Hypertens. 2025;43:1459.
    >> Share

  249. KARTHIKEYAN VJ
    Left ventricular hypertrophy by voltage criteria in hypertension: more than meets the eye?
    J Hypertens. 2025;43:1325-1326.
    >> Share

  250. ZOCCALI C, Mallamaci F
    Decoding the hypertension-kidney connection: implications for black communities.
    J Hypertens. 2025;43:1322-1324.
    >> Share

  251. PASTORE MC, Liga R, Diviggiano EE, Vitale C, et al
    Blood pressure management in clinically complex scenarios: new horizons for a tailored approach.
    J Hypertens. 2025;43:1267-1276.
    >> Share

  252. MORRIS EC, Tucker KL, McManus RJ, Stevens RJ, et al
    The importance of experience: insights into optimal home-blood pressure monitoring regimens from the TASMINH4 Trial.
    J Hypertens. 2025;43:1400-1406.
    >> Share

    July 2025
  253. KINOMURA S, Toyohara T, Chiba Y, Aoki H, et al
    A case of malignant hypertension due to sarcoidosis.
    J Hypertens. 2025 Jul 31. doi: 10.1097/HJH.0000000000004110.
    >> Share

  254. DIAZ-AROCUTIPA C
    Trends of awareness, treatment, and control of hypertension in Peru: a 5-year national survey analysis.
    J Hypertens. 2025 Jul 31. doi: 10.1097/HJH.0000000000004109.
    >> Share

  255. MALOBERTI A, Tognola C, Fumagalli S, Garofani I, et al
    Relationship between pulse wave velocity progression and baseline heart rate and its change over 3.7 years of follow-up in hypertensive patients.
    J Hypertens. 2025 Jul 15. doi: 10.1097/HJH.0000000000004106.
    >> Share

  256. SAGMEISTER P, Asatryan G, Mentzel L, Shahidi P, et al
    Long-term prediction of blood pressure reduction after renal denervation for arterial hypertension.
    J Hypertens. 2025 Jul 7. doi: 10.1097/HJH.0000000000004070.
    >> Share

  257. BITAR YSL, Duraes AR, de Macedo CRB, Aras MG, et al
    Efficacy and safety of sacubitril/valsartan in Afro-descendant patients with resistant hypertension: a randomized controlled trial.
    J Hypertens. 2025 Jul 7. doi: 10.1097/HJH.0000000000004075.
    >> Share


  258. Hypertension determinants among Ghanaians differ according to location of residence: RODAM study: Erratum.
    J Hypertens. 2025;43:1266.
    >> Share

  259. OBEIDAT M
    Editorial commentary on: "assessing the relationship between short-term blood pressure variability and glycation profile in young and middle-aged nondiabetic hypertensive individuals".
    J Hypertens. 2025;43:1146-1147.
    >> Share

  260. LOH HH, Azizan EA, Sukor N
    Connecting the dots: renin-angiotensin-aldosterone system, vitamin D, and hypertension.
    J Hypertens. 2025;43:1136-1145.
    >> Share

  261. RIAR SK, Gillespie S, South AM
    Within-visit blood pressure variability in children and adolescents in the National Health and Nutrition Examination Survey (2013-2020).
    J Hypertens. 2025;43:1158-1168.
    >> Share

  262. MALM EHJ, Petersen AW, Hadad R, Haugaard SB, et al
    Admission blood pressure and blood pressure variability in medical emergency predicts 3-month mortality and readmission.
    J Hypertens. 2025;43:1198-1204.
    >> Share

  263. O'HAGAN ET, Marschner SL, Quintans D, Hillis GS, et al
    Sex differences in blood pressure lowering of initial treatment with ultra-low dose combination therapy versus monotherapy. A secondary analysis of QUARTET.
    J Hypertens. 2025;43:1256-1260.
    >> Share

    June 2025
  264. ISHIDA S, Shinohara Y, Sakaguchi T, Katsuki S, et al
    Triglyceride-glucose index and incidence of hypertension, a population-based observational study of the Japanese population.
    J Hypertens. 2025 Jun 27. doi: 10.1097/HJH.0000000000004087.
    >> Share

  265. ASMAR I, Almahmoud O, Jaghama M
    Prevalence, awareness, and risk factors affecting hypertension according to 2017 American College of Cardiology and American Heart Association guidelines: a cross-sectional study from a developing country.
    J Hypertens. 2025 Jun 24. doi: 10.1097/HJH.0000000000004089.
    >> Share

  266. LI X, Tia MD, Bos JHJ, Schuiling-Veninga CCM, et al
    LASSO logistic regression and cluster analysis in predicting adherence and drug patterns among new users of monotherapy for antihypertensive drugs.
    J Hypertens. 2025 Jun 23. doi: 10.1097/HJH.0000000000004084.
    >> Share

  267. SHARMAN JE, Schutte AE, Nelson MR, Samarawickrama AL, et al
    Automated office blood pressure measurement: a Hypertension Australia and National Hypertension Taskforce of Australia position statement.
    J Hypertens. 2025 Jun 19. doi: 10.1097/HJH.0000000000004079.
    >> Share

  268. SUN J, Zhang W, Wang X, Zhao X, et al
    Betaine protects cerebral microvascular endothelium and ameliorates hypertension-induced cognitive dysfunction via upregulation of the endothelial nitric oxide synthase/nitric monoxide signaling pathway.
    J Hypertens. 2025 Jun 13. doi: 10.1097/HJH.0000000000004085.
    >> Share

  269. DE LA SIERRA A, Ruilope LM, Staplin N, Stergiou GS, et al
    Mortality risks in different subtypes of white-coat hypertension: implications for the diagnosis of white-coat hypertension.
    J Hypertens. 2025 Jun 10. doi: 10.1097/HJH.0000000000004076.
    >> Share

  270. ZHANG W, Yan J, Zhang J, Ge Q, et al
    Blood pressure-lowering efficacy of Sacubitril/Allisartan versus Olmesartan in Chinese hypertensive patients with a nondipping blood pressure pattern.
    J Hypertens. 2025 Jun 6. doi: 10.1097/HJH.0000000000004065.
    >> Share

  271. DIAZ-AROCUTIPA C, Salguero-Bodes R, Puerto E, Martin-Asenjo R, et al
    Sex disparities in awareness, treatment, and control of hypertension in Peru.
    J Hypertens. 2025 Jun 6. doi: 10.1097/HJH.0000000000004072.
    >> Share

  272. DODULIK J
    Response to Dr Hassan's letter regarding our article Pharmacotherapy of arterial hypertension in patients with psoriasis.
    J Hypertens. 2025;43:1087-1088.
    >> Share

  273. HASSAN IN
    Critical appraisal of antihypertensive therapy in psoriasis: limitations and future directions.
    J Hypertens. 2025;43:1086.
    >> Share

  274. COTTRELL EC
    Commentary on: "Long-term cardiovascular repercussions in women with previous pregnancies complicated by severe hypertensive disease".
    J Hypertens. 2025;43:949-950.
    >> Share

  275. GNANENTHIRAN SR, Delgado S, Mirabito Colafella KM, Schlaich MP, et al
    Changing the paradigm of long-term blood pressure control: a systematic review of novel therapies.
    J Hypertens. 2025;43:917-928.
    >> Share

  276. QIAN J, Zhou Z, Zheng Y, Rong S, et al
    Catheter-based ultrasound nerve stimulation and selective renal denervation: a preliminary case series study.
    J Hypertens. 2025;43:1083-1085.
    >> Share

  277. LIP S, Tran TQB, Hanna R, Nichol S, et al
    Long-term effects of SARS-CoV-2 infection on blood vessels and blood pressure - LOCHINVAR.
    J Hypertens. 2025;43:1057-1065.
    >> Share

  278. COCA A, Borghi C, Stergiou GS, Ly NF, et al
    Long-term event rates, risk factors, and treatment pattern in 1.4 million individuals qualifying for dual blood pressure lowering therapy.
    J Hypertens. 2025;43:993-1002.
    >> Share

  279. KULKARNI S, Parati G, Bangalore S, Bilo G, et al
    Blood pressure variability: a review.
    J Hypertens. 2025;43:929-938.
    >> Share

  280. PALSMA T, Claassen JAHR, Richard E, De Heus RAA, et al
    Day-to-day blood pressure variability in older persons - optimizing measurement.
    J Hypertens. 2025;43:970-975.
    >> Share

    May 2025
  281. MINARI TP, de Rosso VV, Manzano CF, Humsi MJ, et al
    Correlation of the Mediterranean-Dietary Approaches to Stop Hypertension diet vs. ultra-processed diet with health outcomes in type 2 diabetes and hypertension: new insights from a 12-month interventional study.
    J Hypertens. 2025 May 21. doi: 10.1097/HJH.0000000000004061.
    >> Share

  282. LIN T, Jiang W, Lin Y, Zhang M, et al
    Association between cardiorespiratory fitness and pediatric primary hypertension: a case-control study in China.
    J Hypertens. 2025 May 21. doi: 10.1097/HJH.0000000000004036.
    >> Share

  283. PARATI G, Pengo MF, Avolio A, Azizi M, et al
    Nocturnal blood pressure: pathophysiology, measurement and clinical implications. position paper of the European Society of Hypertension.
    J Hypertens. 2025 May 19. doi: 10.1097/HJH.0000000000004053.
    >> Share

  284. STOUTENBURG EG, Bravo MC, Howard VJ, Judd SE, et al
    Factor IX and incident hypertension in Black and White adults: the REasons for Geographic and Racial Differences in Stroke cohort.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004045.
    >> Share

  285. EDDISON CHUNG HUNG C, Kocherry C, George J
    Breaking down resistance: novel aldosterone synthase inhibitors in the management of resistant hypertension.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004055.
    >> Share

  286. WYSZYNSKA J, Luszczki E, Seeman T, Simonetti GD, et al
    Hypertension in children with intellectual disabilities: a population not to be overseen.
    J Hypertens. 2025 May 15. doi: 10.1097/HJH.0000000000004052.
    >> Share

  287. ZHANG L, Liu J
    Spironolactone protects against hypertension-induced renal fibrosis by promoting autophagy and inhibiting the NLRP3 inflammasome.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004020.
    >> Share

  288. SINGAL AM, Howard VJ, Judd SE, Carson AP, et al
    Association between serum adiponectin and risk of incident hypertension: the REGARDS study.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004057.
    >> Share

  289. DEGENAAR A, Kruger R, Jacobs A, Pieters M, et al
    Differential associations between kidney and vascular health biomarkers in young adults stratified by blood pressure status: The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension study.
    J Hypertens. 2025 May 14. doi: 10.1097/HJH.0000000000004051.
    >> Share

  290. JAGADESH G, A R R, Nagarajan S
    Effect of systemic hypertension on retinal layers in patients without retinopathy.
    J Hypertens. 2025 May 6. doi: 10.1097/HJH.0000000000004042.
    >> Share

  291. HU L, Li J, Wang W, Li Y, et al
    Hypertension accelerates the development of a diabetic nephropathy model with more relevant clinical features in Dahl salt-sensitive rat.
    J Hypertens. 2025 May 2. doi: 10.1097/HJH.0000000000004038.
    >> Share

  292. PIKKEMAAT M, Atkins ER, Rodgers A, Schutte AE, et al
    Treating hypertension with single pill combinations: a simple strategy to save costs for the patients and payers.
    J Hypertens. 2025 May 2. doi: 10.1097/HJH.0000000000004050.
    >> Share

  293. FAVA C, Dal Pont C, Sartorio A, Contro A, et al
    Local release of renin unveils intrarenal arterial fibromuscular dysplasia.
    J Hypertens. 2025;43:909-913.
    >> Share

  294. SEALEY JE, Blumenfeld JD
    Hypothesis: Reactive increases in plasma renin activity attenuate the fall in blood pressure caused by salt depletion and renin-angiotensin system inhibition.
    J Hypertens. 2025;43:739-746.
    >> Share

  295. LEIVA SISNIEGUEZ CE, Olano RD, Stavile RN, Minetto J, et al
    Is the heart rate dipping pattern associated with sleep quality during an ambulatory blood pressure monitoring? A cross-sectional study.
    J Hypertens. 2025;43:790-796.
    >> Share

    April 2025
  296. LI H, Sun R, Li Y, Yue X, et al
    Controversies in hypertension therapy: bedtime dosing or daytime dosing?
    J Hypertens. 2025 Apr 24. doi: 10.1097/HJH.0000000000004035.
    >> Share

  297. NADERI H, Ramirez J, Van Duijvenboden S, Ruiz Pujadas E, et al
    Diagnostic and prognostic value of ECG-predicted hypertension-mediated left ventricular hypertrophy using machine learning.
    J Hypertens. 2025 Apr 24. doi: 10.1097/HJH.0000000000004034.
    >> Share

  298. VAZQUEZ-AGRA N, Barrera-Lopez L, Marques-Afonso AT, Cruces-Sande A, et al
    Assessing the relationship between short-term blood pressure variability and glycation profile in young and middle-aged nondiabetic hypertensive individuals.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004029.
    >> Share

  299. WANG A, Koshiaris C, Archer L, Riley RD, et al
    Developing prediction models for electrolyte abnormalities in patients indicated for antihypertensive therapy: evidence-based treatment and monitoring recommendations.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004032.
    >> Share

  300. LIN RT, Gao JW, Yang YC, Chen XW, et al
    Optimizing benefits of intensive SBP control in type 2 diabetes: the crucial role of angiotensin-converting enzyme inhibitors/angiotensin-II type 2 receptor blockers.
    J Hypertens. 2025 Apr 22. doi: 10.1097/HJH.0000000000004037.
    >> Share

  301. JAIN A
    A young woman with severe renovascular hypertension due to essential thrombocytosis: case report and literature review.
    J Hypertens. 2025 Apr 8. doi: 10.1097/HJH.0000000000004031.
    >> Share

  302. RENNA NF, Ramirez EI, Vissani S, Farez BG, et al
    Optimizing hypertension management: the impact of drug class, socioeconomic factors, and simplified regimens on medication adherence. VATAHTA study.
    J Hypertens. 2025 Apr 7. doi: 10.1097/HJH.0000000000004023.
    >> Share

  303. RAO KD, Marklund M, Cherukupalli R, Yao Z, et al
    Health financing interventions and hypertension control: a narrative review and hypothetical model.
    J Hypertens. 2025 Apr 3. doi: 10.1097/HJH.0000000000004021.
    >> Share

  304. DANSER AHJ, Deinum J
    Antihypertensive drug treatment: are we ready for the future?
    J Hypertens. 2025 Apr 2. doi: 10.1097/HJH.0000000000004019.
    >> Share

  305. SACO-LEDO G, Ruilope LM, Lucia A
    Response to letter 'Are individuals with resistant hypertension not responsive to exercise when using ambulatory blood pressure monitoring?'.
    J Hypertens. 2025;43:725-726.
    >> Share

  306. SANTOS LP, Umpierre D
    Resistant hypertension and responsiveness to exercise in ambulatory blood pressure monitoring: concerns regarding a study by Saco-Ledo et al.
    J Hypertens. 2025;43:722-723.
    >> Share

  307. IATRIDI F, Theodorakopoulou MP, Georgiou A, Sarafidis PA, et al
    Understanding hypertension following solid organ transplantation: current trends and future perspectives.
    J Hypertens. 2025;43:720-721.
    >> Share

  308. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    In defense of beta-blockers: a critical role in primary hypertension management.
    J Hypertens. 2025;43:719-720.
    >> Share

  309. FORMAN R, Xin X, Kim C, Kernan WN, et al
    A failure to launch: blood pressure control after stroke in a regional health system.
    J Hypertens. 2025;43:715-718.
    >> Share

  310. SHARMAN JE, Takeuchi F, Protogerou A, Weber T, et al
    Prospective relationships between left ventricular mass, brachial and central blood pressures in participants from the UK Biobank.
    J Hypertens. 2025;43:698-704.
    >> Share

  311. ALMEIDA TP, Perruchoud D, Alexandre J, Vermare P, et al
    Evaluation of Aktiia cuffless blood pressure monitor across 24-h, daytime, and night-time measurements versus ambulatory monitoring: a prospective, single-centre observational study.
    J Hypertens. 2025;43:690-697.
    >> Share

    March 2025
  312. HARKNESS T, Wilkinson K, Loo YK, Howard VJ, et al
    Cell adhesion molecules and incident hypertension in black and white adults: the REGARDS study.
    J Hypertens. 2025 Mar 31. doi: 10.1097/HJH.0000000000004004.
    >> Share

  313. BENAVIDES-ROCA LA, Parra G, Zamuner AR
    Effects of a single session of low- and high-intensity velocity-based resistance exercise on blood pressure in patients with hypertension.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004015.
    >> Share

  314. GROVER S, Mishra HP, Gupta R, Gupta LK, et al
    Effect of telemonitoring and home blood pressure monitoring on blood pressure reduction in hypertensive adults: a network meta-analysis.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004008.
    >> Share

  315. KUNUTSOR SK, Connelly MA, Shah A, Bakker SJL, et al
    Associations of high-density lipoprotein cholesterol, particles and subspecies with the risk of hypertension: findings from the PREVEND prospective study.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004014.
    >> Share

  316. HUTTL M, Miklovic M, Gawrys O, Molnar M, et al
    The treatment with soluble guanylate cyclase stimulator BAY41-8543 prevents malignant hypertension and associated organ damage.
    J Hypertens. 2025 Mar 27. doi: 10.1097/HJH.0000000000004009.
    >> Share

  317. GUO X, Qian J, Lai J, Wang H, et al
    Predictive value of pulmonary to systemic vascular resistance ratio in systemic lupus erythematosus patients with pulmonary arterial hypertension.
    J Hypertens. 2025 Mar 21. doi: 10.1097/HJH.0000000000004010.
    >> Share

  318. VERARDINO RGS, Macedo TA, Rodrigues S, Hong VC, et al
    Long-term cardiovascular repercussions in women with previous pregnancies complicated by severe hypertensive disease.
    J Hypertens. 2025 Mar 19. doi: 10.1097/HJH.0000000000003999.
    >> Share

  319. XU D, Liu H, Yang J
    Assessing causal relationships between gut microbiotas, metabolites, and pulmonary arterial hypertension through univariate Mendelian randomization study and bioinformatics analysis.
    J Hypertens. 2025 Mar 19. doi: 10.1097/HJH.0000000000004003.
    >> Share

  320. MIDDELKAMP M, Steffens PS, Vogelsang V, Schild R, et al
    Severe neurovascular hypertension in a 17-year-old girl cured by microvascular decompression.
    J Hypertens. 2025 Mar 10. doi: 10.1097/HJH.0000000000003986.
    >> Share

  321. XU XY, Zhang M, Qin Q, Xue R, et al
    KAT7 contributes to ponatinib-induced hypertension by promoting endothelial senescence and inflammatory responses through activating NF-kappaB signaling pathway.
    J Hypertens. 2025 Mar 10. doi: 10.1097/HJH.0000000000003979.
    >> Share

  322. PAOLETTI E, Ruotolo C, Marzano F, Borrelli S, et al
    The impact of left ventricular ejection fraction on cardiovascular and renal outcome in hypertensive patients with nondialysis chronic kidney disease.
    J Hypertens. 2025 Mar 7. doi: 10.1097/HJH.0000000000004000.
    >> Share

  323. MARUHASHI T, Kinoshita Y, Ozono R, Nakamura M, et al
    Nighttime blood pressure-targeted antihypertensive treatment.
    J Hypertens. 2025 Mar 6. doi: 10.1097/HJH.0000000000003998.
    >> Share

  324. DURUKAN BN, Ozcan EB, Saglam M, Sener YZ, et al
    Validity and reliability of the 6-min stepper test in hypertensive individuals.
    J Hypertens. 2025 Mar 6. doi: 10.1097/HJH.0000000000003996.
    >> Share

  325. KAUR A, Ricciardelli S, Rajah N, Pilote L, et al
    Sex differences in the association between hypertension, cerebral small vessel disease and cognitive decline: a narrative review.
    J Hypertens. 2025 Mar 3. doi: 10.1097/HJH.0000000000003997.
    >> Share

  326. WANG H, Zhou Z, Zhang L, Yu F, et al
    Sedentary behavior modified the association between depression and risk of all-cause deaths in hypertensive population.
    J Hypertens. 2025;43:474-480.
    >> Share

  327. DI GIOIA G, Ferrera A, Maestrini V, Monosilio S, et al
    Abnormal blood pressure response to exercise and ventricular arrhythmias: a suspicious association in athletes.
    J Hypertens. 2025;43:513-520.
    >> Share

  328. MOORTHY M, Kandula NR, Lancki N, Siddique J, et al
    Association of diastolic blood pressure and coronary artery calcium in South Asian American adults.
    J Hypertens. 2025;43:538-543.
    >> Share

  329. BYTYQI V, Kannenkeril D, Striepe K, Bosch A, et al
    Predicting blood pressure response to renal denervation based on a new approach.
    J Hypertens. 2025;43:413-419.
    >> Share

  330. ALVES MAM, Bezerra R, Dal Pont CS, Mota-Gomes MA, et al
    Relationship between blood pressure variability and blood pressure phenotypes: a home blood pressure monitoring study.
    J Hypertens. 2025;43:456-463.
    >> Share

    February 2025
  331. VOSKAMP LW, Rousian M, Koerts JJ, Steegers-Theunissen RPM, et al
    Risk factors for chronic hypertension 5 years after a pregnancy complicated by preeclampsia: a systematic review and meta-analysis.
    J Hypertens. 2025 Feb 28. doi: 10.1097/HJH.0000000000003995.
    >> Share

  332. WANG Y, Zhang Q, Shen C, Wang H, et al
    Decreased adenosine 3',5'-cyclic monophosphate is a driving factor of P300/SIRT1-mediated histone hyperacetylation in obesity-related hypertension.
    J Hypertens. 2025 Feb 28. doi: 10.1097/HJH.0000000000003981.
    >> Share

  333. CHEDDANI L, Lelong H, Goldberg M, Zins M, et al
    Prediction of incidence of hypertension in France and associated factors: results from the CONSTANCES cohort.
    J Hypertens. 2025 Feb 24. doi: 10.1097/HJH.0000000000003989.
    >> Share

  334. VAHTERA V, Pajarinen JS, Kivimaki M, Ervasti J, et al
    Incidence of new onset arterial hypertension after metabolic bariatric surgery: an 8-year prospective follow-up with matched controls.
    J Hypertens. 2025 Feb 24. doi: 10.1097/HJH.0000000000003993.
    >> Share

  335. DODULIK J, Dodulikova L, Plasek J, Ramik Z, et al
    Pharmacotherapy of arterial hypertension in patients with psoriasis.
    J Hypertens. 2025 Feb 18. doi: 10.1097/HJH.0000000000003982.
    >> Share

  336. KOLLER A, Jarai Z, Takacs J
    Development of the European Society of Hypertension guidelines for the management of arterial hypertension: comparison of the helpfulness of ESH 2013, 2018, and 2023 guidelines.
    J Hypertens. 2025 Feb 14. doi: 10.1097/HJH.0000000000003985.
    >> Share

  337. LI C, Wu S, Lei B, Zang W, et al
    Effect of aerobic exercise on endothelial function in hypertensive and prehypertensive patients: a systematic review and meta-analysis of randomized controlled trials.
    J Hypertens. 2025 Feb 13. doi: 10.1097/HJH.0000000000003980.
    >> Share

  338. MORICONI D, Nannipieri M, Badhwar S, Taddei S, et al
    Impact of kidney function on stiffness of small conduit arteries in hypertension and obesity.
    J Hypertens. 2025 Feb 7. doi: 10.1097/HJH.0000000000003957.
    >> Share

  339. MARTIN A, Lang S, Schifferdecker F, Allo G, et al
    Nocturnal hypertension represents an uncontrolled burden in patients with metabolic dysfunction-associated steatotic liver disease.
    J Hypertens. 2025 Feb 4. doi: 10.1097/HJH.0000000000003977.
    >> Share


  340. The use of loop diuretics in the context of hypertensive disorders of pregnancy: a systematic review and meta-analysis: Erratum.
    J Hypertens. 2025;43:369.
    >> Share

  341. KAWADA T
    Self-rated health and clinical outcomes in patients with hypertension: a dose-response relationship.
    J Hypertens. 2025;43:365.
    >> Share

  342. OSAMA M, Ubaid S, Ullah U, Ubaid M, et al
    Serum neutrophil gelatinase-associated lipocalin and cystatin C as predictors of hypertension in ex-preterm children later in life.
    J Hypertens. 2025;43:364-365.
    >> Share

  343. LUE E, Shamilov DD, Lo DF
    Correspondence to "Association between liver fat level and risk of hypertension: evidence from a Chinese health examination dataset".
    J Hypertens. 2025;43:362-363.
    >> Share

  344. POOS S, Hassan N, Jin S, Chuadhry I, et al
    A rheumatological perspective on hypertension: a role for disease-modifying antirheumatic drugs?
    J Hypertens. 2025;43:359-360.
    >> Share

  345. ALI MA, Zeng M, Alkuhali AA, Zeng Z, et al
    Toll-like receptor 4 inhibition by pyridostigmine is associated with a reduction in hypertension and inflammation in rat models of preeclampsia.
    J Hypertens. 2025;43:336-350.
    >> Share

  346. TAGETTI A, Cattazzo F, Marcon D, Romano S, et al
    Subclinical target organ damage in a sample of children and adolescents with solitary functioning kidney. A pilot study.
    J Hypertens. 2025;43:221-227.
    >> Share

  347. CAPPUCCIO FP, Manfredini R, Pigazzani F
    Chronotherapy of hypertension: let's not throw the baby out with the bathwater!
    J Hypertens. 2025;43:201-202.
    >> Share

  348. BANGALORE S, Maqsood MH, Bakris GL, Rao SV, et al
    Renal denervation - radiofrequency vs. ultrasound: insights from a mixed treatment comparison meta-analysis of randomized sham controlled trials.
    J Hypertens. 2025;43:325-335.
    >> Share

  349. WONG HJ, Toh KZX, Teo YH, Teo YN, et al
    Effects of glucagon-like peptide-1 receptor agonists on blood pressure in overweight or obese patients: a meta-analysis of randomized controlled trials.
    J Hypertens. 2025;43:290-300.
    >> Share

  350. WANG M, Collings PJ, Jang H, Chen Z, et al
    Prospective associations of genetic susceptibility to high blood pressure and muscle strength with incident cardiovascular disease outcomes.
    J Hypertens. 2025;43:280-289.
    >> Share

  351. PATHAK A, Weber MA, Poulos C, Cohen SA, et al
    Impact of expected blood pressure reduction on patient preferences for pharmaceutical and renal denervation treatment.
    J Hypertens. 2025;43:228-235.
    >> Share

    January 2025
  352. NGUYEN DV, Pham GT, Pham SN, Nguyen HTT, et al
    Efficacy and safety of sacubitril-valsartan in hypertension patients with end-stage kidney disease on maintenance dialysis: a meta-analysis.
    J Hypertens. 2025 Jan 30. doi: 10.1097/HJH.0000000000003972.
    >> Share

  353. ORABONA R, Monaci R, Branca S, Sartorello S, et al
    Chronic hypertension in pregnancy: insights into adverse outcomes prevention.
    J Hypertens. 2025 Jan 30. doi: 10.1097/HJH.0000000000003978.
    >> Share

  354. NEMATI D, Noriega de la Colina AE, Wright KD, Joseph JJ, et al
    An I-Change approach to understanding exercise determinants among black individuals with hypertension.
    J Hypertens. 2025 Jan 28. doi: 10.1097/HJH.0000000000003974.
    >> Share

  355. CUSPIDI C, Facchetti R, Gherbesi E, Quarti-Trevano F, et al
    Increased arterial stiffness and left ventricular remodelling as markers of masked hypertension: findings from the PAMELA population.
    J Hypertens. 2025 Jan 23. doi: 10.1097/HJH.0000000000003970.
    >> Share

  356. ZHANG GY, Fan JR, Wang ZH, He Q, et al
    Treatment of early hypertensive renal damage with Quanduzhong capsules: two case reports.
    J Hypertens. 2025 Jan 23. doi: 10.1097/HJH.0000000000003966.
    >> Share

  357. MALOBERTI A, Rebora P, Occhino G, Andreano A, et al
    Carotid-femoral pulse wave velocity progression in hypertensive patients is associated with subsequent cardiovascular outcomes.
    J Hypertens. 2025 Jan 23. doi: 10.1097/HJH.0000000000003973.
    >> Share

  358. ALTIN CELIK P, Aytekin M
    Extracellular matrix dynamics in a rat model of pulmonary arterial hypertension: unveiling the role of hyaluronan in disease pathology.
    J Hypertens. 2025 Jan 17. doi: 10.1097/HJH.0000000000003967.
    >> Share

  359. STERGIOU GS, Kyriakoulis KG, Kollias A, McManus RJ, et al
    Blood pressure measurement at kiosks in public spaces: systematic review and consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability endorsed by the International Society of
    J Hypertens. 2025 Jan 14. doi: 10.1097/HJH.0000000000003965.
    >> Share

  360. FERRAO D, Nogueira-Silva L, Tavares S, Lima MJ, et al
    A case of renovascular hypertension due to polyarteritis nodosa.
    J Hypertens. 2025 Jan 3. doi: 10.1097/HJH.0000000000003963.
    >> Share


  361. Hypertension and obstructive sleep apnoea syndrome in adults with heart failure in nigeria: clinical correlates and association with clinical outcomes: Erratum.
    J Hypertens. 2025;43:183.
    >> Share

  362. KHAN S, Ahmad B, Khan MWZ, Fatima SM, et al
    Mechanisms of thiazide-induced hypertension treatment: insights from gene expression and histological analysis in malignant stroke-prone spontaneously hypertensive rats.
    J Hypertens. 2025;43:180-181.
    >> Share

  363. STECKO W, Wanczura P, Wajhajmer A, Wisniowski M, et al
    Chronic total occlusion of renal artery in symptomatic young patient with resistant hypertension: is a revascularization necessary or redundant?
    J Hypertens. 2025;43:163-167.
    >> Share

  364. WYATT N, Melhem N, Booth C, Newton J, et al
    Successful emergency renal auto-transplantation in a child with renovascular disease.
    J Hypertens. 2025;43:168-172.
    >> Share

  365. DE OLIVEIRA ESV, de Albuquerque NLS, Dordetto PR, Lamas JLT, et al
    Are previously validated blood pressure self-measurement devices accepted under the Universal Standard? A systematic review.
    J Hypertens. 2025;43:35-47.
    >> Share

  366. RECH JS, Postel-Vinay N, Vercamer V, de Villele P, et al
    User engagement with home blood pressure monitoring: a multinational cohort using real-world data collected with a connected device.
    J Hypertens. 2025;43:90-97.
    >> Share

  367. FAIENZA S, Citterio L, Messaggio E, Zagato L, et al
    A novel mouse model recapitulates the effects of rs2254524 variant in the lanosterol synthase gene on salt sensitivity and organ damage.
    J Hypertens. 2025;43:80-89.
    >> Share

  368. MAHMOUD AUM, Caillon A, Shokoples B, Ferreira NS, et al
    Vgamma6/Vdelta1 + gammadelta T cells protect from angiotensin II effects on blood pressure and endothelial function in mice.
    J Hypertens. 2025;43:109-119.
    >> Share

    December 2024
  369. RANASINGHE P, Manchanayake M, Perera T, Liyanage S, et al
    Prevalence and correlates of uncontrolled hypertension and cardiovascular morbidity among patients with hypertension at the largest tertiary care hospital in Sri Lanka.
    J Hypertens. 2024 Dec 23. doi: 10.1097/HJH.0000000000003952.
    >> Share

  370. RANASINGHE P, Perera T, Liyanage S, Manchanayake M, et al
    Hypertension in Sri Lanka: a systematic review of prevalence, control, care delivery and challenges.
    J Hypertens. 2024 Dec 20. doi: 10.1097/HJH.0000000000003953.
    >> Share

  371. KIM JH, Oh S, Hong SJ, Yu CW, et al
    Minimum number of readings necessary for determining long-term visit-to-visit blood pressure variability to predict cardiovascular outcomes in people with diabetes.
    J Hypertens. 2024 Dec 18. doi: 10.1097/HJH.0000000000003954.
    >> Share

  372. DE LA SIERRA A, Ruilope LM, Staplin N, Stergiou GS, et al
    Mortality risks in different subtypes of masked hypertension in the Spanish ambulatory blood pressure monitoring registry.
    J Hypertens. 2024 Dec 17. doi: 10.1097/HJH.0000000000003950.
    >> Share

  373. ZHENG Y, Zhong D, Li J, Zhang Y, et al
    Systemic immune-inflammation index and long-term mortality in patients with hypertension: a cohort study.
    J Hypertens. 2024 Dec 12. doi: 10.1097/HJH.0000000000003927.
    >> Share

  374. YAO J, He X, Wang H, Wang A, et al
    Synergistic effect of anemia and obstructive sleep apnea on hypertension: National Health and Nutrition Examination Survey 2015-2018.
    J Hypertens. 2024 Dec 12. doi: 10.1097/HJH.0000000000003939.
    >> Share

  375. TU Q, Hyun K, Lin S, Hafiz N, et al
    Impacts of hypertension and diabetes on the incidence of cardiovascular diseases and all-cause mortality: findings from the China Health and Retirement Longitudinal Study cohort.
    J Hypertens. 2024 Dec 12. doi: 10.1097/HJH.0000000000003946.
    >> Share

  376. LEONE D, Vallelonga F, Botta M, Cesareo M, et al
    Heart failure with preserved ejection fraction: from echocardiographic characteristics to a cardiovascular damage score in a high-risk hypertensive population.
    J Hypertens. 2024 Dec 11. doi: 10.1097/HJH.0000000000003942.
    >> Share

  377. LEE K, Kim BS, Jeon J, Shin DW, et al
    Resolution of hypertension after kidney transplantation is associated with improved kidney transplant outcomes: a nationwide cohort study.
    J Hypertens. 2024 Dec 9. doi: 10.1097/HJH.0000000000003938.
    >> Share

  378. PINTO D, Teo A, Wijerethne S, Khoo CM, et al
    Remission of persistent hypertension and hypokalaemia following redo adrenalectomy for primary aldosteronism - case report.
    J Hypertens. 2024 Dec 9. doi: 10.1097/HJH.0000000000003944.
    >> Share

  379. SIMONYI G, Burnier M, Narkiewicz K, Rokszin G, et al
    Effect of single-pill versus free equivalent combinations on persistence and major adverse cardiovascular events in hypertension: a real-world analysis.
    J Hypertens. 2024 Dec 5. doi: 10.1097/HJH.0000000000003916.
    >> Share

  380. YSEBAERT L, Protin C, Oberic L, Beziat G, et al
    Ibrutinib pharmacokinetics in B-lymphoproliferative disorders discloses exposure-related incidence of hypertension.
    J Hypertens. 2024 Dec 4. doi: 10.1097/HJH.0000000000003937.
    >> Share

  381. BALDWIN J, Burnier M, Ponte B, Ackermann D, et al
    Association of mid-regional pro-adrenomedullin with office and 24-h ambulatory blood pressure in a Swiss general population sample.
    J Hypertens. 2024;42:2187-2195.
    >> Share

  382. INAGAKI Y, Matsushita K, Appel LJ, Perry HB, et al
    Task-sharing with community health workers to treat hypertension: a scoping review.
    J Hypertens. 2024;42:2041-2054.
    >> Share

  383. TCHIO C, Heydarpour M, Pojoga L, Taylor H, et al
    AGTR1 variant rs2638355 is associated with increased salt sensitivity of blood pressure: a female-specific effect in individuals from the HyperPath cohort.
    J Hypertens. 2024;42:2180-2186.
    >> Share

  384. WILLIAMS JR, Cole MA, Pewowaruk RJ, Hein AJ, et al
    Using an in-office passive leg raise to identify older adults with suboptimal blood pressure control.
    J Hypertens. 2024;42:2155-2163.
    >> Share

  385. TOMITANI N, Hoshide S, Kanegae H, Kario K, et al
    Daytime actisensitivity predicts nocturnal dipping patterns and morning surge in blood pressure: the Home-Activity ICT-based Japan Ambulatory Blood Pressure Monitoring Prospective study.
    J Hypertens. 2024;42:2164-2172.
    >> Share

  386. CHAINOGLOU A, Sarafidis K, Taparkou A, Farmaki E, et al
    Serum neutrophil gelatinase-associated lipocalin and cystatin C is associated with blood pressure in ex-preterm children and adolescents.
    J Hypertens. 2024;42:2196-2205.
    >> Share

    November 2024
  387. WEIHRAUCH T, Lemcke J, Buschges JC, Allen J, et al
    Participation interest and completion of home blood pressure measurements with mailed devices in adults with and without hypertension.
    J Hypertens. 2024 Nov 26. doi: 10.1097/HJH.0000000000003932.
    >> Share

  388. YUAN M, Zhang Y, Zuo N, Lei H, et al
    Association of oxidative balance score with blood pressure, all-cause and cardiovascular disease mortality among hypertensive patients: a prospective study.
    J Hypertens. 2024 Nov 21. doi: 10.1097/HJH.0000000000003931.
    >> Share

  389. SACO-LEDO G, Valenzuela PL, Almazan-Polo J, Plaza-Florido A, et al
    Acute physical exercise and ambulatory blood pressure in resistant hypertension.
    J Hypertens. 2024 Nov 12. doi: 10.1097/HJH.0000000000003924.
    >> Share

  390. DING C, Cao T, Cheng Z, Liu L, et al
    Independent and joint effect of central and brachial SBP on incident stroke in hypertensive adults.
    J Hypertens. 2024 Nov 6. doi: 10.1097/HJH.0000000000003921.
    >> Share

  391. AL-ANI A, Al Suleimani Y, Ritscher S, Toennes SW, et al
    Adherence to antihypertensive medications in Omani patients: a comparison of drug biochemical analysis and the Morisky Medication Adherence Scale.
    J Hypertens. 2024 Nov 4. doi: 10.1097/HJH.0000000000003917.
    >> Share

  392. PELES E, Schreiber S
    Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment.
    J Hypertens. 2024;42:2020.
    >> Share

  393. WANG S, Wong SYS, Yip BHK, Lee EKP, et al
    Response to: Enhancing analytical approaches for investigating the age-dependent association of central blood pressure: UK biobank cohort study.
    J Hypertens. 2024;42:2019.
    >> Share

  394. BHATT R, Stepanyan A, Wasif U, Shamilov DD, et al
    Enhancing analytical approaches for investigating the age-dependent association of central blood pressure: UK biobank cohort study.
    J Hypertens. 2024;42:2018.
    >> Share

  395. THAPA N, Shamilov DD, Lo DF
    Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment.
    J Hypertens. 2024;42:1895-1896.
    >> Share

  396. NILSSON PM, Pikkemaat M, Schutte AE
    Sustainable hypertension care - a new strategy for an expanding problem.
    J Hypertens. 2024;42:1891-1894.
    >> Share

  397. COCA A, Sebba-Barroso WK
    High blood pressure variability in middle age and cognitive decline in the elderly: the search for better predictors of dementia.
    J Hypertens. 2024;42:1889-1890.
    >> Share

  398. ZHANG R, Yin H, Yang M, Liu J, et al
    Advanced progress of the relationship between renin-angiotensin-aldosterone system inhibitors and cancers.
    J Hypertens. 2024;42:1862-1873.
    >> Share

  399. DONG S, Yu B, Yin C, Li Y, et al
    Associations between PM 2.5 and its chemical constituents and blood pressure: a cross-sectional study.
    J Hypertens. 2024;42:1897-1905.
    >> Share

  400. WU GJ, Si AM, Wang Y, Chu C, et al
    Associations of ultra long-term visit-to-visit blood pressure variability, since childhood with vascular aging in midlife: a 30-year prospective cohort study.
    J Hypertens. 2024;42:1948-1957.
    >> Share

  401. MELGAREJO JD, Vatcheva KP, Mejia-Arango S, Charisis S, et al
    Association of longitudinal changes in 24-h blood pressure level and variability with cognitive decline.
    J Hypertens. 2024;42:1985-1993.
    >> Share

  402. XU X, Catts VS, Harris K, Wang N, et al
    The contribution of cumulative blood pressure load to dementia, cognitive function and mortality in older adults.
    J Hypertens. 2024;42:1922-1931.
    >> Share

    October 2024
  403. ZHANG J, Wang J, Zhou X, Chen S, et al
    Serum autotaxin positively associates with hypertension in postmenopausal women: a single center study in China.
    J Hypertens. 2024 Oct 30. doi: 10.1097/HJH.0000000000003922.
    >> Share

  404. JAE SY, Yoon ES, Kim HJ, Cho MJ, et al
    Isometric handgrip versus aerobic exercise: a randomized trial evaluating central and ambulatory blood pressure outcomes in older hypertensive participants.
    J Hypertens. 2024 Oct 30. doi: 10.1097/HJH.0000000000003919.
    >> Share

  405. SANCHEZ R (CHAIR), Coca A (Co-Chair), de Salazar DIM, Alcocer L, et al
    2024 Latin American Society of Hypertension guidelines on the management of arterial hypertension and related comorbidities in Latin America.
    J Hypertens. 2024 Oct 25. doi: 10.1097/HJH.0000000000003899.
    >> Share

  406. ALKETBI LB, Al Hashaikeh B, Fahmawee T, Sahalu Y, et al
    Hypertension and its determinants in Abu Dhabi population: a retrospective cohort study.
    J Hypertens. 2024 Oct 24. doi: 10.1097/HJH.0000000000003907.
    >> Share

  407. MARTINHO LCAP, Zaniqueli D, Andreazzi AE, Oliveira CM, et al
    Association between early menarche and hypertension in pre and postmenopausal women: Baependi Heart Study.
    J Hypertens. 2024 Oct 17. doi: 10.1097/HJH.0000000000003908.
    >> Share

  408. BRGULJAN HITIJ J, Gaciong Z, Simic D, Vajer P, et al
    Differences in sex and age response to single pill combination based antihypertensive therapy reflecting in blood pressure and arterial stiffness.
    J Hypertens. 2024 Oct 17. doi: 10.1097/HJH.0000000000003901.
    >> Share

  409. SCHWOTZER N, Lu Y, Halfon M, Pascual M, et al
    Prevalence of hypertension and uncontrolled hypertension after solid organ transplantation: a 5-year follow-up of the Swiss Transplant Cohort Study.
    J Hypertens. 2024 Oct 17. doi: 10.1097/HJH.0000000000003905.
    >> Share

  410. BUZINARI TC, Castania JA, Salvador SLS, Ribeiro AB, et al
    Periodontitis accelerates the onset of hypertension in spontaneously hypertensive rats, while the electrical activation of the carotid sinus nerve delays the beginning of the increase in blood pressure.
    J Hypertens. 2024 Oct 14. doi: 10.1097/HJH.0000000000003906.
    >> Share

  411. WANG JX, Xu XY, Wang YM, Chen AD, et al
    Superior cervical ganglionectomy attenuates vascular remodeling in spontaneously hypertensive rats.
    J Hypertens. 2024 Oct 14. doi: 10.1097/HJH.0000000000003883.
    >> Share

  412. DE LUCA G, Nardin M, Algowhary M, Uguz B, et al
    Impact of hypertension on mortality in patients with ST-elevation myocardial infarction undergoing primary angioplasty: insights from the international multicenter ISACS-STEMI registry.
    J Hypertens. 2024 Oct 14. doi: 10.1097/HJH.0000000000003890.
    >> Share

  413. CALCADA A, Costa V, Ledo L, Freire P, et al
    Quick action required: revealing pheochromocytoma as the hidden trigger behind postoperative hypertensive crisis.
    J Hypertens. 2024 Oct 4. doi: 10.1097/HJH.0000000000003882.
    >> Share

  414. RING A, Lo DF
    Assessing coffee's impact on blood pressure: a critical examination of measurement and cultural variations.
    J Hypertens. 2024;42:1834-1836.
    >> Share

  415. MOTIEJUNAITE J, de Pinho NA, Flamant M, Vidal-Petiot E, et al
    Reply to 'Unmasking hypertension in patients with CKD: who to screen and how to confirm the diagnosis?'.
    J Hypertens. 2024;42:1833-1834.
    >> Share

  416. QUARTI-TREVANO F, Mancia G, Grassi G
    Assessing the association between coffee consumption and blood pressure values: when complexity prevails.
    J Hypertens. 2024;42:1832-1833.
    >> Share

  417. GEORGIANOS PI, Vaios V, Karligkiotis A, Liakopoulos V, et al
    Unmasking hypertension in patients with chronic kidney disease: who to screen and how to confirm the diagnosis?
    J Hypertens. 2024;42:1831-1832.
    >> Share

  418. KIM H, Lichtenstein AH, Coresh J, Appel LJ, et al
    Serum protein responses to Dietary Approaches to Stop Hypertension (DASH) and DASH-Sodium trials and associations with blood pressure changes.
    J Hypertens. 2024;42:1823-1830.
    >> Share

  419. RUIZ-SANCHEZ JG, Fernandez Sanchez A, Cardenas-Salas J, Fernandez-Cagigao Y, et al
    Primary aldosteronism prevalence enhanced by strict adherence to 2016 Endocrine Society guidelines: insights from an endocrine hypertension unit.
    J Hypertens. 2024;42:1813-1822.
    >> Share

  420. REBOLDI G, Angeli F, Verdecchia P
    Antihypertensive drugs in the morning or the evening? A complicated question with no clear answer.
    J Hypertens. 2024;42:1684-1686.
    >> Share

  421. LEE EK, Wang S, Ng WL, Ramdzan SN, et al
    Evening dosing versus morning dosing of antihypertensive medications for nocturnal hypertension: a systematic review and meta-analysis of 107 randomized controlled trials.
    J Hypertens. 2024;42:1653-1664.
    >> Share

  422. SATOH M, Metoki H, Kikuya M, Murakami T, et al
    Proposal of reference value for day-to-day blood pressure variability based on two outcomes: the Ohasama study.
    J Hypertens. 2024;42:1769-1776.
    >> Share

  423. PAN X, Chen Y, Yang Y, Kidambi S, et al
    Mediating effects of BMI on the association between DNA methylation regions and 24-h blood pressure in African Americans.
    J Hypertens. 2024;42:1750-1756.
    >> Share

  424. TABARA Y, Matsumoto T, Murase K, Setoh K, et al
    Sleep blood pressure measured using a home blood pressure monitor was independently associated with cardiovascular disease incidence: the Nagahama study.
    J Hypertens. 2024;42:1695-1702.
    >> Share

  425. BOULESTREAU R, Lorthioir A, Dreau H, Persu A, et al
    Baseline characteristics of the first 302 patients included for acute malignant hypertension crisis in the prospective multidisciplinary HAMA cohort.
    J Hypertens. 2024 Oct 1. doi: 10.1097/HJH.0000000000003851.
    >> Share

    September 2024
  426. FLOR AFL, Duarte-Maia S, Fernandes-Costa F, Souza RMP, et al
    Chronic cannabidiol treatment induces cardiovascular improvement in renovascular hypertensive rats.
    J Hypertens. 2024 Sep 30. doi: 10.1097/HJH.0000000000003865.
    >> Share

  427. ZHENG X, Zou P, Zeng C, Liu J, et al
    Increased levels of urine volatile organic compounds are associated with hypertension risk.
    J Hypertens. 2024 Sep 13. doi: 10.1097/HJH.0000000000003878.
    >> Share

  428. KIM HM, Hwang IC, Park J, Choi HJ, et al
    Impact of changes in left heart geometry on predicting new-onset atrial fibrillation in patients with hypertension.
    J Hypertens. 2024 Sep 12. doi: 10.1097/HJH.0000000000003875.
    >> Share

  429. CONNOLLY BJ, Saxton SN
    Recent updates on the influence of iron and magnesium on vascular, renal, and adipose inflammation and possible consequences for hypertension.
    J Hypertens. 2024 Sep 10. doi: 10.1097/HJH.0000000000003829.
    >> Share

  430. PALATINI P, Battista F, Mos L, Rattazzi M, et al
    Reproducibility of daytime hypertension, night-time hypertension, and nocturnal blood pressure dipping patterns in young to middle age patients with stage 1 hypertension.
    J Hypertens. 2024 Sep 10. doi: 10.1097/HJH.0000000000003874.
    >> Share

  431. KARIO K, Williams B, Tomitani N, McManus RJ, et al
    Innovations in blood pressure measurement and reporting technology: International Society of Hypertension position paper endorsed by the World Hypertension League, European Society of Hypertension, Asian Pacific Society of Hypertension, and Latin Amer
    J Hypertens. 2024 Sep 9. doi: 10.1097/HJH.0000000000003827.
    >> Share

  432. BAHAT G, Ribeiro H, Sheppard JP, Bogaerts JMK, et al
    Twelve hot questions in the management of hypertension in patients aged 80+ years and their answers with the help of the 2023 European Society of Hypertension Guidelines.
    J Hypertens. 2024 Sep 5. doi: 10.1097/HJH.0000000000003844.
    >> Share

  433. DOKU A, Asamoah KT, Amaechi MU, Auala T, et al
    The development of Africa's first unified hypertension management guidelines.
    J Hypertens. 2024 Sep 2. doi: 10.1097/HJH.0000000000003864.
    >> Share

  434. KAZIBWE R, Muhammad AI, Singleton MJ, Evans JK, et al
    Self-rated health and risk of incident cardiovascular events among individuals with hypertension.
    J Hypertens. 2024;42:1573-1580.
    >> Share

  435. GREENSTEIN AS
    Don't forget to check your blood pressure.
    J Hypertens. 2024;42:1528.
    >> Share

  436. COTTRELL EC
    Commentary on: 'Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes'.
    J Hypertens. 2024;42:1523-1524.
    >> Share

  437. RUBIN S, Tomaszewski M
    Self-rated health in hypertension: navigating the complexities of cardiovascular risk prediction.
    J Hypertens. 2024;42:1521-1522.
    >> Share

  438. SALUJA S, Darlay R, Lennon R, Keavney BD, et al
    Whole -genome survival analysis of 144 286 people from the UK Biobank identifies novel loci associated with blood pressure.
    J Hypertens. 2024;42:1647-1652.
    >> Share

  439. ZHANG W, Li QY, Guo ZH, Zhang CY, et al
    Report on three cases of familial primary aldosteronism type IV.
    J Hypertens. 2024;42:1641-1646.
    >> Share

  440. HINDERLITER AL, Lin FC, Yang Y, Viera LA, et al
    The utility of home blood pressure load in predicting average self-measured blood pressure.
    J Hypertens. 2024;42:1624-1631.
    >> Share

  441. OMBONI S, Alfie J, Arystan A, Avolio A, et al
    Association of 24-h central hemodynamics and stiffness with cardiovascular events and all-cause mortality. The VASOTENS Registry.
    J Hypertens. 2024;42:1590-1597.
    >> Share

    August 2024
  442. AIZAWA K, Jordan AN, Gooding KM, Llewellyn DJ, et al
    Aortic reservoir-excess pressure parameters are associated with worse cognitive function in people with untreated stage II/III hypertension.
    J Hypertens. 2024 Aug 30. doi: 10.1097/HJH.0000000000003853.
    >> Share

  443. HAMDAN R, Baldassini AL, Vilcan A, Alan G, et al
    Finger SBP measurement as a way to manage hypertension in patients with markedly calcified arteries: a case report.
    J Hypertens. 2024 Aug 28. doi: 10.1097/HJH.0000000000003849.
    >> Share

  444. WANG X, Shaw JE, Yu J, Jennings G, et al
    Prevalence, awareness, treatment, and control rates of hypertension in the general population of Australia: a systematic review and meta-analysis.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003854.
    >> Share

  445. FERRARI R, Carpes LO, Domingues LB, Schneider VM, et al
    Recreational beach tennis training reduces ambulatory blood pressure in adults with hypertension: a randomized clinical trial.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003850.
    >> Share

  446. WANG N, Chalmers J, Harris K, Poulter N, et al
    Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial.
    J Hypertens. 2024 Aug 27. doi: 10.1097/HJH.0000000000003855.
    >> Share

  447. ASHENAGAR MS, Higashino T, Matsumoto A, Higashino H, et al
    Mechanisms of thiazide-induced hypertension treatment: insights from gene expression and histological analysis in malignant stroke-prone spontaneously hypertensive rats.
    J Hypertens. 2024 Aug 22. doi: 10.1097/HJH.0000000000003837.
    >> Share

  448. FRANCHI M, Torrigiani G, Kjeldsen SE, Mancia G, et al
    Long-term exposure to antihypertensive drugs and the risk of cancer occurrence: evidence from a large population-based study.
    J Hypertens. 2024 Aug 14. doi: 10.1097/HJH.0000000000003841.
    >> Share

  449. KOVELL LC, Denu M, Revoori R, Sadaniantz K, et al
    Barriers and facilitators to home blood pressure monitoring in women with pregnancies complicated by hypertensive disorders: a qualitative study.
    J Hypertens. 2024 Aug 12. doi: 10.1097/HJH.0000000000003835.
    >> Share

  450. BAVARESCO GAMBASSI B, Schwingel PA
    Dynamic power training combined with endurance training reduces arterial stiffness and improves hemodynamic parameters in older adults diagnosed with grade 1 hypertension?
    J Hypertens. 2024;42:1461-1462.
    >> Share

  451. SALUJA S
    Reflections on the 2023 European Society of Hypertension summer school: a participant's perspective.
    J Hypertens. 2024;42:1460-1461.
    >> Share

  452. MA X, Zhuo Y, Zhang Z, Yang Y, et al
    Association of T-cell receptor repertoires and arterial stiffness in patients with essential hypertension.
    J Hypertens. 2024;42:1440-1448.
    >> Share

  453. DUPREZ DA, Jacobs DR Jr
    Hypertension and OMICS, quo vadis.
    J Hypertens. 2024;42:1307-1308.
    >> Share

  454. ZHANG Y, Sun Q, Yu C, Sun D, et al
    Associations of traditional cardiovascular risk factors with 15-year blood pressure change and trajectories in Chinese adults: a prospective cohort study.
    J Hypertens. 2024;42:1340-1349.
    >> Share

    July 2024
  455. NEMCSIK J, Takacs J, Kekk Z, Farsang C, et al
    White-coat effect and masked hypertension in patients with high-normal office blood pressure: results of the Hungarian ABPM Registry.
    J Hypertens. 2024 Jul 30. doi: 10.1097/HJH.0000000000003825.
    >> Share

  456. BOSCH A, Rauh M, Striepe K, Schiffer M, et al
    Renal adaptation in pre-obesity patients with hypertension.
    J Hypertens. 2024 Jul 22. doi: 10.1097/HJH.0000000000003821.
    >> Share

  457. SANCHEZ RA, Sanchez MJ, Pessana F, Ramirez AJ, et al
    Insulin resistance is associated to future hypertension in normotensive salt-sensitive individuals: a 10-year follow-up study.
    J Hypertens. 2024 Jul 15. doi: 10.1097/HJH.0000000000003810.
    >> Share

  458. LARKINS NG, Choong C, Schlaich M, Quinlan C, et al
    Defining childhood hypertension: is it too complicated? An evaluation of the potential impact of different approaches in an Australian paediatric population.
    J Hypertens. 2024 Jul 15. doi: 10.1097/HJH.0000000000003815.
    >> Share

  459. YAMANAKA K, Suzuki M, Pham LT, Tomita K, et al
    Involvement of D1 dopamine receptor in the nucleus of the solitary tract of rats in stress-induced hypertension and exercise.
    J Hypertens. 2024 Jul 5. doi: 10.1097/HJH.0000000000003809.
    >> Share

  460. KOS M, Nad T, Stupin A, Drenjancevic I, et al
    Juvenile primary hypertension is associated with attenuated macro- and microvascular dilator function independently of body weight.
    J Hypertens. 2024 Jul 5. doi: 10.1097/HJH.0000000000003812.
    >> Share

  461. MUNTNER P, Shimbo D, Schwartz JE
    Does nondipping blood pressure provide prognostic information for all-cause and cardiovascular mortality independent of nighttime blood pressure?
    J Hypertens. 2024;42:1151-1153.
    >> Share

  462. SAXENA M
    Vaccines against angiotensin receptors as a potential treatment for hypertension.
    J Hypertens. 2024;42:1150.
    >> Share

  463. SALUJA S, Lennon R
    Exploring novel therapeutic opportunities for hypertension: a paradigm-shifting approach via integrative multiomic analysis, pioneering the path to precision medicine.
    J Hypertens. 2024;42:1147-1149.
    >> Share

  464. MESSERLI FH, Schoenenberger-Berzins R, Messerli AW
    Why the lack of enthusiasm for renal denervation?
    J Hypertens. 2024;42:1145-1146.
    >> Share

  465. MANCIA G, Schumacher H, Bohm M, Grassi G, et al
    Impact of seasonal blood pressure changes on visit-to-visit blood pressure variability and related cardiovascular outcomes.
    J Hypertens. 2024;42:1269-1281.
    >> Share

  466. AF GEIJERSTAM P, Radholm K, Jonasson L, Lindahl TL, et al
    P-selectin and C-reactive protein in relation to home blood pressure and coronary calcification: a SCAPIS substudy.
    J Hypertens. 2024;42:1226-1234.
    >> Share

  467. DE LA SIERRA A, Staplin N, Ruilope LM, Gorostidi M, et al
    A blunted nocturnal blood pressure decline is associated with all-cause and cardiovascular mortality.
    J Hypertens. 2024;42:1197-1202.
    >> Share

    June 2024
  468. SUN Y, Qi X, Wang X, Lin X, et al
    Association between liver fat level and risk of hypertension: evidence from a Chinese health examination dataset.
    J Hypertens. 2024 Jun 26. doi: 10.1097/HJH.0000000000003803.
    >> Share

  469. YAP HJ, Lim JJJ, Tan SD, Ang CS, et al
    Effectiveness of digital health interventions on adherence and control of hypertension: a systematic review and meta-analysis.
    J Hypertens. 2024 Jun 25. doi: 10.1097/HJH.0000000000003793.
    >> Share

  470. PHAM MHC, Kuhl JT, Fuchs A, Sigvardsen PE, et al
    Determinants of thoracic aortic size in normotensive and hypertensive individuals.
    J Hypertens. 2024 Jun 25. doi: 10.1097/HJH.0000000000003792.
    >> Share

  471. KOH S, Kim D, Kim M, Kim T, et al
    Aerobic exercise effects on systolic blood pressure and endothelial inflammation in obese and non-obese elderly women with isolated systolic hypertension.
    J Hypertens. 2024 Jun 20. doi: 10.1097/HJH.0000000000003794.
    >> Share

  472. WANG J, Xu Y, Zhu J, Wu B, et al
    Multimodal data-driven, vertical visualization prediction model for early prediction of atherosclerotic cardiovascular disease in patients with new-onset hypertension.
    J Hypertens. 2024 Jun 18. doi: 10.1097/HJH.0000000000003798.
    >> Share

  473. WOJCIECHOWSKA W, Rajzer M, Kreutz R, Weber T, et al
    The impact of the COVID-19 pandemic on blood pressure control in patients with treated hypertension-results of the European Society of Hypertension Study (ESH ABPM COVID-19 Study).
    J Hypertens. 2024 Jun 13. doi: 10.1097/HJH.0000000000003752.
    >> Share


  474. Dietary factors and hypertension risk in West Africa: a systematic review and meta-analysis of observational studies: Erratum.
    J Hypertens. 2024;42:1108.
    >> Share

  475. PEETERS LEJ, Koch BCP, Versmissen J
    Reply to 'optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension'.
    J Hypertens. 2024;42:1106-1107.
    >> Share

  476. RUBIN D, Lo DF, Jammula S, Carroll N, et al
    Optimizing treatment outcomes: integrating antihypertensive drug concentration measurement, personalized feedback, and psychosocial factors in resistant hypertension.
    J Hypertens. 2024;42:1105-1106.
    >> Share

  477. MINETTO J, Cuello MB, Dominici FP, Caniffi C, et al
    Circulating angiotensin-(1-7) is decreased in patients with isolated nocturnal hypertension.
    J Hypertens. 2024;42:1101-1104.
    >> Share

  478. ZHOU YF, Ye YX, Chen JX, Zhang YB, et al
    Circulating metabolic biomarkers and risk of new-onset hypertension: findings from the UK Biobank.
    J Hypertens. 2024;42:1066-1074.
    >> Share

  479. CAMARGO LL, Trevelin SC, da Silva GHG, Dos Santos Dias AA, et al
    Protein disulfide isomerase-mediated transcriptional upregulation of Nox1 contributes to vascular dysfunction in hypertension.
    J Hypertens. 2024;42:984-999.
    >> Share

  480. KREUTZ R, Brunstrom M, Burnier M, Grassi G, et al
    Beta-blocker bashing and downgrading in hypertension management: a fashionable trend representing a matter of concern.
    J Hypertens. 2024;42:966-967.
    >> Share

  481. CHARCHAR FJ
    Wake up and enjoy the coffee without worrying about your blood pressure!
    J Hypertens. 2024;42:965.
    >> Share

  482. LATOSINSKA A, Siwy J, Mischak H
    Multiomics: paving the path towards personalized prevention of hypertension.
    J Hypertens. 2024;42:962-964.
    >> Share

  483. RUILOPE LM
    Commentary on 'Prevalence and factors associated with masked hypertension in chronic kidney disease'.
    J Hypertens. 2024;42:961.
    >> Share

  484. TREVANO FQ, Vela-Bernal S, Facchetti R, Cuspidi C, et al
    Habitual coffee consumption and office, home, and ambulatory blood pressure: results of a 10-year prospective study.
    J Hypertens. 2024;42:1094-1100.
    >> Share

  485. NOLDE JM, Atkins E, Marschner S, Hillis GS, et al
    Ambulatory blood pressure after 12 weeks of quadruple combination of quarter doses of blood pressure medication vs. standard medication.
    J Hypertens. 2024;42:1009-1018.
    >> Share

  486. KOKKO E, Choudhary MK, Mutanen A, Honkonen M, et al
    Volume overload is a major characteristic in primary aldosteronism: a 3-year follow-up study.
    J Hypertens. 2024;42:1057-1065.
    >> Share

  487. VRIEND EMC, Bouwmeester TA, Franco OH, Galenkamp H, et al
    Sex differences in blood pressure phenotypes over time - the HELIUS study.
    J Hypertens. 2024;42:977-983.
    >> Share

    May 2024
  488. XU J, Wang JJ, Zhao QH, Gong SG, et al
    Pulmonary vascular resistance predicts the mortality in patients with bronchiectasis-associated pulmonary hypertension.
    J Hypertens. 2024 May 28. doi: 10.1097/HJH.0000000000003782.
    >> Share

  489. ZEIJEN VJM, Peeters LEJ, Asman A, Boersma E, et al
    Quality-of-life and beliefs about medication in relation to a therapy adherence intervention in resistant hypertension: the Resistant HYpertension: MEasure to ReaCh Targets trial.
    J Hypertens. 2024 May 24. doi: 10.1097/HJH.0000000000003780.
    >> Share

  490. ZHAO H, Wen P, Xu Q, Zi Y, et al
    Association of sleep traits with risk of hypertensive disorders of pregnancy: a mendelian randomization study.
    J Hypertens. 2024 May 22. doi: 10.1097/HJH.0000000000003771.
    >> Share

  491. GRASSI G
    Thirty-five years of the European Society of Hypertension: from past to future.
    J Hypertens. 2024 May 22. doi: 10.1097/HJH.0000000000003778.
    >> Share

  492. DORDEVIC DB, Koracevic GP, Dordevic AD, Lovic DB, et al
    Hypertension and left ventricular hypertrophy.
    J Hypertens. 2024 May 16. doi: 10.1097/HJH.0000000000003774.
    >> Share

  493. SCHLAICH MP, Tsioufis K, Taddei S, Ferri C, et al
    Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement.
    J Hypertens. 2024 May 15. doi: 10.1097/HJH.0000000000003769.
    >> Share

  494. SHAHRBABAKI SS, Liu X, Baumert M
    Finger pulse plethysmography predicts gestational hypertension, preeclampsia and gestational diabetes.
    J Hypertens. 2024 May 15. doi: 10.1097/HJH.0000000000003775.
    >> Share

  495. HALIMI JM, Sarafidis P, Azizi M, Bilo G, et al
    Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire.
    J Hypertens. 2024 May 14. doi: 10.1097/HJH.0000000000003756.
    >> Share

  496. ROSSI GP, Bagordo D, Rossi FB, Pintus G, et al
    'Essential' arterial hypertension: time for a paradigm change.
    J Hypertens. 2024 May 9. doi: 10.1097/HJH.0000000000003767.
    >> Share

  497. CHEN Z, Wei D, Zhao M, Shi J, et al
    Associations of serum glucocorticoid levels on hypertension and blood pressure-related indicators: a nested case-control study in rural China.
    J Hypertens. 2024 May 8. doi: 10.1097/HJH.0000000000003758.
    >> Share

  498. HUA D, Huang W, Huang W, Xie Q, et al
    TRPV1 signaling of perirenal adipose tissue promotes DOCA-Salt-induced hypertension and kidney injury.
    J Hypertens. 2024 May 2. doi: 10.1097/HJH.0000000000003748.
    >> Share

  499. CASIGLIA E
    AND, OR, AND/OR in hypertension guidelines.
    J Hypertens. 2024;42:934-935.
    >> Share

  500. HUTCHINGS DC, Heagerty AM
    Sleeping unsoundly: CPAP and its complexities in treating sleep apnoea hypertension.
    J Hypertens. 2024;42:766-767.
    >> Share

  501. BRASIL IA, Silva JCPL, Pescatello LS, Farinatti P, et al
    Central and peripheral mechanisms underlying postexercise hypotension: a scoping review.
    J Hypertens. 2024;42:751-763.
    >> Share

  502. WANG S, Wong SYS, Yip BHK, Lee EKP, et al
    Age-dependent association of central blood pressure with cardiovascular outcomes: a cohort study involving 34 289 participants using the UK biobank.
    J Hypertens. 2024;42:769-776.
    >> Share

  503. CELLER BG, Yong A, Rubenis I, Butlin M, et al
    Accurate detection of Korotkoff sounds reveals large discrepancy between intra-arterial systolic pressure and simultaneous noninvasive measurement of blood pressure with brachial cuff sphygmomanometry.
    J Hypertens. 2024;42:873-882.
    >> Share

  504. NATALE P, Palmer SC, Jaure A, Saglimbene V, et al
    Blood pressure lowering for kidney transplant recipients: systematic review with network meta-analysis.
    J Hypertens. 2024;42:848-855.
    >> Share

  505. SESA-ASHTON G, Carnagarin R, Nolde JM, Muente I, et al
    Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation.
    J Hypertens. 2024;42:922-927.
    >> Share

    April 2024
  506. WANG JG, Topouchian J, Bricout-Hennel S, Mu J, et al
    Efficacy and safety of a single-pill versus free combination of perindopril/indapamide/amlodipine: a multicenter, randomized, double-blind study in Chinese patients with hypertension.
    J Hypertens. 2024 Apr 25. doi: 10.1097/HJH.0000000000003741.
    >> Share

  507. XU ZQ, Li XZ, Zhu R, Ge R, et al
    Asprosin contributes to vascular remodeling in hypertensive rats via superoxide signaling.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003751.
    >> Share

  508. FARAH BQ, Forjaz CLM, O'Driscoll JM, Millar PJ, et al
    Characteristics associated with responsiveness to isometric handgrip training in medicated hypertensive patients: secondary data analysis.
    J Hypertens. 2024 Apr 23. doi: 10.1097/HJH.0000000000003749.
    >> Share

  509. HUGHES AD, Davey Smith G, Howe LD, Lawlor D, et al
    Differences between brachial and aortic blood pressure in adolescence and their implications for diagnosis of hypertension.
    J Hypertens. 2024 Apr 16. doi: 10.1097/HJH.0000000000003743.
    >> Share

  510. CHE J, Tong J, Kuang X, Zheng C, et al
    Hyperuricemia and gout enhanced the risk of long-term mortality in hypertension: insights from the National Health and Nutrition Examination Survey 2007-2018.
    J Hypertens. 2024 Apr 16. doi: 10.1097/HJH.0000000000003744.
    >> Share

  511. SHANTSILA E, Beevers DG, Lip GYH
    For Debate: The 2023 European Society of Hypertension guidelines - cause for concern.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003733.
    >> Share

  512. SHARP ASP, Sanderson A, Hansell N, Reddish K, et al
    Renal denervation for uncontrolled hypertension: a systematic review and meta-analysis examining multiple subgroups.
    J Hypertens. 2024 Apr 15. doi: 10.1097/HJH.0000000000003727.
    >> Share

  513. THOMOPOULOS C, Hitij JB, De Backer T, Gkaliagkousi E, et al
    Management of hypertensive disorders in pregnancy: a Position Statement of the European Society of Hypertension Working Group 'Hypertension in Women'.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003739.
    >> Share

  514. PALERMITI A, Pappaccogli M, Rabbia F, D'Avolio A, et al
    Multiple drug intolerance in antihypertensive patients: what is known and what is missing.
    J Hypertens. 2024 Apr 12. doi: 10.1097/HJH.0000000000003737.
    >> Share

  515. SASON A, Adelson M, Leshno D, Schreiber S, et al
    Occurrence of hypertension among patients with opioid use disorder in methadone maintenance treatment.
    J Hypertens. 2024 Apr 11. doi: 10.1097/HJH.0000000000003740.
    >> Share

  516. KYRIAKOULIS KG, Kollias A, Bilo G, Soranna D, et al
    Blood pressure variability assessed by office, home, and ambulatory measurements before and during antihypertensive drug treatment: a sub-analysis of the REVERENT randomized trial.
    J Hypertens. 2024 Apr 5. doi: 10.1097/HJH.0000000000003730.
    >> Share

  517. KEISER T, Katz S, Robson SM, Greaney JL, et al
    Association between time-of-day for eating, exercise, and sleep with blood pressure in adults with elevated blood pressure or hypertension: a systematic review.
    J Hypertens. 2024 Apr 3. doi: 10.1097/HJH.0000000000003732.
    >> Share

  518. BAVARESCO GAMBASSI B, Chaves LFC, Sousa TMDS, Ribeiro MJS, et al
    Short-duration dynamic power training with elastic bands combined with endurance training: a promising approach to hypertension management in older adults.
    J Hypertens. 2024;42:735-742.
    >> Share

  519. FERREIRA MJ, Dias DDS, Silva GDC, de Araujo AA, et al
    Concurrent exercise training potentiates the effects of angiotensin-converting enzyme inhibitor on regulatory systems of blood pressure control in ovariectomized hypertensive rats.
    J Hypertens. 2024;42:650-661.
    >> Share

  520. SASAKI N, Maeda R, Ozono R, Yoshimura K, et al
    Differences in the impact of newly diagnosed type 2 diabetes on cardiovascular mortality between normotensive and hypertensive individuals.
    J Hypertens. 2024;42:610-619.
    >> Share

  521. SALUJA S
    A critical commentary on the use of combined power and endurance training for hypertension management in older adults.
    J Hypertens. 2024;42:605-606.
    >> Share

  522. BARCELLOS PAM, Dall'Agnol A, Sandi GM, Remonti LR, et al
    Dietary approach for the treatment of arterial hypertension in patients with diabetes mellitus.
    J Hypertens. 2024;42:583-593.
    >> Share

  523. ZHOU T, Gu S, Shao F, Li P, et al
    Prediction of preeclampsia from retinal fundus images via deep learning in singleton pregnancies: a prospective cohort study.
    J Hypertens. 2024;42:701-710.
    >> Share

  524. ASTUDILLO Y, Kibrom S, Pereira T, Solomon S, et al
    Association between anxiety and elevated blood pressure in adolescent patients: a single-center cross-sectional study.
    J Hypertens. 2024;42:644-649.
    >> Share

  525. WADA A, Kabayama M, Godai K, Kido M, et al
    Factors influencing the continuation of home blood pressure measurement in community-dwelling older adults: the NOSE study.
    J Hypertens. 2024;42:694-700.
    >> Share

    March 2024
  526. MAVROGEORGIS E, Kondyli M, Mischak H, Vlahou A, et al
    Multiple urinary peptides are associated with hypertension: a link to molecular pathophysiology.
    J Hypertens. 2024 Mar 29. doi: 10.1097/HJH.0000000000003726.
    >> Share

  527. BERILLO O, Comeau K, Caillon A, Leclerc S, et al
    CD28-expressing delta T cells are increased in perivascular adipose tissue of hypertensive mice and in subcutaneous adipose tissue of obese humans.
    J Hypertens. 2024 Mar 27. doi: 10.1097/HJH.0000000000003725.
    >> Share

  528. LIN J, Costa JO, Pearson SA, Buckley NA, et al
    Impact of coordinated care on adherence to antihypertensive medicines among adults experiencing polypharmacy in Australia.
    J Hypertens. 2024 Mar 14. doi: 10.1097/HJH.0000000000003721.
    >> Share

  529. WANG Z, Li W, Jiang C, Wang J, et al
    Association between blood pressure variability and risk of kidney function decline in hypertensive patients without chronic kidney disease: a post hoc analysis of Systolic Blood Pressure Intervention Trial study.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003715.
    >> Share

  530. WU J, Wu Z, Kuang W, Shi D, et al
    Combined vaccines against angiotensin II receptor type 1 and alpha 1D-adrenergic receptor for hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003710.
    >> Share

  531. GUO J, Jia P, Gu Z, Tang W, et al
    Altered gut microbiota and metabolite profiles provide clues in understanding resistant hypertension.
    J Hypertens. 2024 Mar 11. doi: 10.1097/HJH.0000000000003716.
    >> Share

  532. PALATINI P, Kollias A, Saladini F, Asmar R, et al
    Assessment and management of exaggerated blood pressure response to standing and orthostatic hypertension: consensus statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability.
    J Hypertens. 2024 Mar 4. doi: 10.1097/HJH.0000000000003704.
    >> Share

  533. WATZ MES, Tivesten A, Ottarsdottir K, Li Y, et al
    Reply on: Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:580-581.
    >> Share

  534. PATEL J, Amin K, Lo DF
    Analyzing the effects of sex hormone-binding globulin levels and development of hypertension in middle-aged men and women.
    J Hypertens. 2024;42:579-580.
    >> Share

  535. ZHENG X, Lei Y, Cheng XW
    Resolvin D1 as a novel target in the management of hypertension.
    J Hypertens. 2024;42:393-395.
    >> Share

  536. KOLLIAS A, Kyriakoulis KG, Komnianou A, Stathopoulou P, et al
    Prognostic value of home versus ambulatory blood pressure monitoring: a systematic review and meta-analysis of outcome studies.
    J Hypertens. 2024;42:385-392.
    >> Share

  537. NAITO Y, Yasumura S, Okuno K, Asakura M, et al
    Hypoxia-inducible factor-prolyl hydroxylase inhibitor Roxadustat (FG-4592) reduces renal fibrosis in Dahl salt-sensitive rats.
    J Hypertens. 2024;42:497-505.
    >> Share

  538. LOO G, Puar T, Foo R, Ong TK, et al
    Unique characteristics of Asians with hypertension: what is known and what can be done?
    J Hypertens. 2024 Mar 1. doi: 10.1097/HJH.0000000000003706.
    >> Share

    February 2024
  539. BERSCH-FERREIRA AC, Machado RHV, de Oliveira JS, Santos RHN, et al
    Effectiveness of a two-component nutritional strategy for blood pressure control in individuals with hypertension users of a public health system: a randomized controlled clinical trial.
    J Hypertens. 2024 Feb 26. doi: 10.1097/HJH.0000000000003703.
    >> Share

  540. LANG X, Peng C, Zhang Y, Gao R, et al
    Correlation between systolic blood pressure and mortality in heart failure patients with hypertension.
    J Hypertens. 2024 Feb 16. doi: 10.1097/HJH.0000000000003693.
    >> Share

  541. CARRY BJ, Miller WL
    Blood volume phenotypes and patient sex in resistant hypertension.
    J Hypertens. 2024 Feb 15. doi: 10.1097/HJH.0000000000003688.
    >> Share

  542. LEGRAND F, Motiejunaite J, Arnoult F, Lahens A, et al
    Prevalence and factors associated with masked hypertension in chronic kidney disease.
    J Hypertens. 2024 Feb 12. doi: 10.1097/HJH.0000000000003680.
    >> Share

  543. RAMIREZ-CARRACEDO R, Hernandez I, Moreno-Gomez-Toledano R, Diez-Mata J, et al
    NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis.
    J Hypertens. 2024 Feb 6. doi: 10.1097/HJH.0000000000003679.
    >> Share

  544. CHUNNAN L, Shaomei S, Wannian L
    Sleep and risk of hypertension in general American adults: reply.
    J Hypertens. 2024;42:382-383.
    >> Share

  545. SCORZA FA, Bombardi LM, de Almeida AG, Finsterer J, et al
    Hypertension: the dramatic rise in dangerous pesticides found on fruits and vegetables.
    J Hypertens. 2024;42:381-382.
    >> Share

  546. GUAN T, Cao M, Zheng C, Zhou H, et al
    Dose-response association between physical activity and blood pressure among Chinese adults: a nationwide cross-sectional study.
    J Hypertens. 2024;42:360-370.
    >> Share

  547. FRAVEL MA, Ernst ME, Woods RL, Beilin L, et al
    Long-term blood pressure variability and frailty risk in older adults.
    J Hypertens. 2024;42:244-251.
    >> Share

  548. KARELIUS S, Pentti J, Juhanoja E, Jula A, et al
    Association of work-related psychosocial factors and day-to-day home blood pressure variation: the Finn-Home study.
    J Hypertens. 2024;42:337-343.
    >> Share

  549. NEWTON J, Haseler E, Higgins C, Futcher C, et al
    Reliability of systolic blood pressure measured by parents in young children at home using a hand held doppler device and aneroid sphygmomanometer.
    J Hypertens. 2024;42:308-314.
    >> Share

  550. ZAMAN S, Raj IS, Yang AWH, Lindner R, et al
    Exercise training reduces arterial stiffness in women with high blood pressure: a systematic review and meta-analysis.
    J Hypertens. 2024;42:197-204.
    >> Share

  551. LIU N, Gong Z, Li Y, Xu Y, et al
    CTRP3 inhibits myocardial fibrosis through the P2X7R-NLRP3 inflammasome pathway in SHR rats.
    J Hypertens. 2024;42:315-328.
    >> Share

  552. MARQUES ER, Bernardino AC, Alvim RO, Schreiber R, et al
    Relationship of blood pressure measured in the calf with arm blood pressure and arterial stiffness: a general population study.
    J Hypertens. 2024;42:301-307.
    >> Share

  553. ZHANG L, Wang W, Gong J, Wang X, et al
    Development, validation, and clinical utility of a risk prediction model for recurrent preeclampsia.
    J Hypertens. 2024;42:236-243.
    >> Share

    January 2024
  554. SAGARA K, Goto K, Maeda M, Murata F, et al
    Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the life study.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003661.
    >> Share

  555. YE XF, Wang WY, Wang XY, Huang QF, et al
    Seasonal variation in ambulatory blood pressure control in patients on clinic blood pressure-guided antihypertensive treatment.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003666.
    >> Share

  556. EGAN BM, Li J, Sutherland SE, Rakotz MK, et al
    Greater use of antihypertensive medications explains lower blood pressures and better control in statin-treated than statin-eligible untreated adults.
    J Hypertens. 2024 Jan 18. doi: 10.1097/HJH.0000000000003656.
    >> Share

  557. KIM BS, Lee Y, Shin JH, Heo R, et al
    Blood pressure and variability responses to the down-titration of antihypertensive drugs.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003668.
    >> Share

  558. OKEKUNLE AP, Asowata OJ, Akpa OM, Fakunle AG, et al
    Dietary patterns associated with hypertension among stroke-free indigenous Africans: insights from the Stroke Investigative Research and Educational Network study.
    J Hypertens. 2024 Jan 17. doi: 10.1097/HJH.0000000000003662.
    >> Share


  559. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Asso
    J Hypertens. 2024;42:194.
    >> Share

  560. ABDELAZEEM B, Saleh O, Mahmoud A, Abuelazm M, et al
    Authors' response to "Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings".
    J Hypertens. 2024;42:191-192.
    >> Share

  561. FERNANDEZ JR, Mojon A, Smolensky MH, Hermida RC, et al
    Impact of hypertension treatment-time on cardiovascular outcomes: erroneous trial selection leading to suspect findings.
    J Hypertens. 2024;42:190-191.
    >> Share

  562. KREUTZ R, Palatini P, Stergiou G, Mancia G, et al
    Orthostatic hypotension an important phenotype in the 2023 European Society of Hypertension guidelines: how to measure it?
    J Hypertens. 2024;42:188-189.
    >> Share

  563. PAIVA AMG, Gomes MICM, Silva EAA, Feitosa ADM, et al
    Should arm positioning matter in the diagnosis of orthostatic hypotension and hypertension?
    J Hypertens. 2024;42:186-188.
    >> Share

  564. ARMANINI D, Sabbadin C, Manso J, Boscaro M, et al
    Consideration in the evaluation of follow-up of resistant hypertension.
    J Hypertens. 2024;42:56-57.
    >> Share

  565. OSCULLO G, Gomez-Olivas JD, Martinez-Garcia MA
    Nocturnal hypertension phenotypes and obstructive sleep apnoea.
    J Hypertens. 2024;42:50-52.
    >> Share

  566. RABBITT L, Curneen J, Hobbins A, Browne D, et al
    A cost-analysis of managing secondary and apparent treatment-resistant hypertension in a specialist multidisciplinary hypertension clinic.
    J Hypertens. 2024;42:58-69.
    >> Share

  567. KISHI T
    Gender differences in the association of serum uric acid with left ventricular hypertrophy should be focused.
    J Hypertens. 2024;42:53-55.
    >> Share

  568. OSMAN MMA, Mullins E, Kleprlikova H, Wilkinson IB, et al
    Beetroot juice, exercise, and cardiovascular function in women planning to conceive.
    J Hypertens. 2024;42:101-108.
    >> Share

  569. SNYMAN JR, Bortolotto LA, Degli Esposti L, Jayagopal PB, et al
    A real-world analysis of outcomes and healthcare costs of patients on perindopril/indapamide/amlodipine single-pill vs. multiple-pill combination in Italy.
    J Hypertens. 2024;42:136-142.
    >> Share

  570. SHANTSILA E, Shantsila A, Williams N, Lip GYH, et al
    Left ventricular hypertrophy and mortality in ethnic minority groups in the UK: e-ECHOES study.
    J Hypertens. 2024;42:95-100.
    >> Share

  571. GHERBESI E, Faggiano A, Sala C, Carugo S, et al
    Uric acid and left ventricular hypertrophy: a gender-based meta-analysis of echocardiographic studies.
    J Hypertens. 2024;42:109-117.
    >> Share

  572. PANAGIOTAKOS D, Antza C, Kotsis V
    Ambulatory and home blood pressure monitoring for cardiovascular disease risk evaluation: a systematic review and meta-analysis of prospective cohort studies.
    J Hypertens. 2024;42:1-9.
    >> Share

    December 2023
  573. GIBSON R, Aljuraiban GS, Oude-Griep LM, Vu TH, et al
    Relationship of calcium and magnesium intakes with the dietary approaches to stop hypertension score and blood pressure: the International Study of Macro/micronutrients and Blood Pressure.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003648.
    >> Share

  574. GAN J, Shi Y, Zhao R, Li D, et al
    Adipose c-Jun NH2-terminal kinase promotes angiotensin II-induced and deoxycorticosterone acetate salt-induced hypertension and vascular dysfunction by inhibition of adiponectin production and activation of SGK1 in mice.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003649.
    >> Share

  575. WANG L, Li C, Li Z, Li Q, et al
    Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    J Hypertens. 2023 Dec 21. doi: 10.1097/HJH.0000000000003650.
    >> Share

  576. SERRA MO, de Macedo LR, Silva M, Lautner RQ, et al
    Effect of Vitamin D supplementation on blood pressure in hypertensive individuals with hypovitaminosis D: a systematic review and meta-analysis.
    J Hypertens. 2023 Dec 19. doi: 10.1097/HJH.0000000000003646.
    >> Share

  577. SATHEESH G, Dhurjati R, Huffman MD, Rosende A, et al
    Standardized treatment protocols for hypertension: global availability, characteristics, and alignment with the hypertension guideline recommendations.
    J Hypertens. 2023 Dec 18. doi: 10.1097/HJH.0000000000003636.
    >> Share

  578. SALMAN UA, Schwartz JG, McMahan AC, Michalek JE, et al
    Rapid Gastric emptying in spontaneously hypertensive rats.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003640.
    >> Share

  579. SASAGAWA Y, Inoue Y, Futagami K, Nakamura T, et al
    Application of deep neural survival networks to the development of risk prediction models for diabetes mellitus, hypertension, and dyslipidemia.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003626.
    >> Share

  580. CIFKOVA R, Harazny JM, Bruthans J, Wohlfahrt P, et al
    Early vascular damage in retinal microcirculation in arterial hypertension: the Czech post-MONICA study.
    J Hypertens. 2023 Dec 14. doi: 10.1097/HJH.0000000000003637.
    >> Share

  581. CRUZ-LOPEZ EO, Ye D, Stolk DG, Clahsen-van Groningen MC, et al
    Combining renin-angiotensin system blockade and sodium-glucose cotransporter-2 inhibition in experimental diabetes results in synergistic beneficial effects.
    J Hypertens. 2023 Dec 11. doi: 10.1097/HJH.0000000000003633.
    >> Share

  582. ATASOY S, Henningsen P, Johar H, Middeke M, et al
    Hypertension in the first blood pressure reading and the risk of cardiovascular disease mortality in the general population: findings from the prospective KORA study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003629.
    >> Share

  583. KIM Y, Kim J, Kang E, Im DW, et al
    The association of time-updated ambulatory blood pressure and renal progression in hypertensive patients with chronic kidney disease: post hoc analysis of ACCURATE study.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003625.
    >> Share

  584. BOTHE TL, Kreutz R, Glos M, Patzak A, et al
    Simultaneous 24-h ambulatory blood pressure measurement on both arms: a consideration for improving hypertension management.
    J Hypertens. 2023 Dec 7. doi: 10.1097/HJH.0000000000003632.
    >> Share

  585. THOMOPOULOS C
    Target blood pressure in isolated systolic hypertension: a meta-analysis of randomized outcome trials.
    J Hypertens. 2023;41:2113-2114.
    >> Share

  586. RAM CVS
    The latest hypertension guidelines: from encryption to decryption, finally!
    J Hypertens. 2023;41:2072-2073.
    >> Share

    November 2023
  587. NAKAGAWA K, Chen R, Ross GW, Donlon TA, et al
    FOXO3 longevity genotype attenuates the impact of hypertension on cerebral microinfarct risk.
    J Hypertens. 2023 Nov 23. doi: 10.1097/HJH.0000000000003620.
    >> Share

  588. XIONG Y, He Y, Chen Z, Wu T, et al
    Lactobacillus induced by irbesartan on spontaneously hypertensive rat contribute to its antihypertensive effect.
    J Hypertens. 2023 Nov 17. doi: 10.1097/HJH.0000000000003613.
    >> Share

  589. HALE G, Puchades E, Jacomino G, El-Mcharfie L, et al
    Use trends of chlorthalidone and hydrochlorothiazide among United States adults with hypertension: National Health and Nutrition Examination Survey 2009-2018.
    J Hypertens. 2023 Nov 16. doi: 10.1097/HJH.0000000000003622.
    >> Share

  590. KIM JH, Joo HJ, Chung SH, Yum Y, et al
    Cardiovascular outcomes according to on-treatment systolic blood pressure in older hypertensive patients: a multicenter cohort using a common data model.
    J Hypertens. 2023 Nov 15. doi: 10.1097/HJH.0000000000003544.
    >> Share

  591. BUDZYN M, Gryszczynska B, Begier-Krasinska B, Kaja E, et al
    Decreased toll-like receptor 4 and CD11b/CD18 expression on peripheral monocytes of hypertensive patients correlates with a lesser extent of endothelial damage: a preliminary study.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003617.
    >> Share

  592. JOYCE OC, McHugh C, Mockler D, Wilson F, et al
    Midlife hypertension is a risk factor for some, but not all, domains of cognitive decline in later life: a systematic review and meta-analysis.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003614.
    >> Share

  593. STEFANI LD, Trivedi SJ, Ferkh A, Emerson P, et al
    Left atrial mechanics evaluated by two-dimensional strain analysis: alterations in essential hypertension.
    J Hypertens. 2023 Nov 9. doi: 10.1097/HJH.0000000000003615.
    >> Share

  594. WEI C, Zhang J, Peng S, Liu J, et al
    Resolvin D1 attenuates Ang II-induced hypertension in mice by inhibiting the proliferation, migration and phenotypic transformation of vascular smooth muscle cells by blocking the RhoA/mitogen-activated protein kinase pathway.
    J Hypertens. 2023 Nov 7. doi: 10.1097/HJH.0000000000003610.
    >> Share

  595. QIU W, Cai A, Li L, Feng Y, et al
    Association of depression trajectories and subsequent hypertension and cardiovascular disease: findings from the CHARLS cohort.
    J Hypertens. 2023 Nov 2. doi: 10.1097/HJH.0000000000003609.
    >> Share


  596. Interferon regulatory factor 4 deletion protects against kidney inflammation and fibrosis in deoxycorticosterone acetate/salt hypertension: Erratum.
    J Hypertens. 2023;41:1872.
    >> Share


  597. Prevalence of non-steroidal anti-inflammatory drugs (NSAIDS) use in patients with hypertensive crisis: Erratum.
    J Hypertens. 2023;41:1871.
    >> Share


  598. PS-P12-8: The prevalence of hypertension in factory employees, detected during the periodic examination at the factory: Erratum.
    J Hypertens. 2023;41:1868.
    >> Share

  599. TABARA Y
    Reply to 'Phenotyping sleep hypertension; never forgetting the night'.
    J Hypertens. 2023;41:1867.
    >> Share

  600. CUSPIDI C, Gherbesi E, Tadic M
    Phenotyping masked hypertension: do not forget the night.
    J Hypertens. 2023;41:1865-1866.
    >> Share

  601. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Carvedilol in patients with cirrhosis and arterial hypertension: two birds with one stone.
    J Hypertens. 2023;41:1864-1865.
    >> Share

  602. ANDERSSON U, Nilsson PM, Kjellgren K, Hoffmann M, et al
    Reply to 'Examining the impact of E-health management on hypertension'.
    J Hypertens. 2023;41:1864.
    >> Share

  603. FATIMA HE, Lo DF
    Examining the impact of E-health management on hypertension.
    J Hypertens. 2023;41:1863.
    >> Share

  604. CARDOSO AM, Aneli NM, Lammers M, Manica A, et al
    Resistance training reduces platelet activation in hypertensive women: the role of purinergic signaling.
    J Hypertens. 2023;41:1745-1752.
    >> Share

  605. SHI M, Liu Y, Wang S, Wang R, et al
    Blood pressure control and antihypertensive medication use after discharge and prognosis of ischemic stroke.
    J Hypertens. 2023;41:1730-1737.
    >> Share

  606. SHOKOPLES BG, Berillo O, Comeau K, Chen HY, et al
    P2RX7 gene knockout or antagonism reduces angiotensin II-induced hypertension, vascular injury and immune cell activation.
    J Hypertens. 2023;41:1701-1712.
    >> Share

  607. SULICKA-GRODZICKA J, Guzik TJ
    The ATP connection: a new therapeutic promise of P2X7 targeting in hypertension and vascular injury.
    J Hypertens. 2023;41:1696-1698.
    >> Share

  608. SONG J, Tan M, Wang C, Brown MK, et al
    Salt intake, blood pressure and cardiovascular disease mortality in England, 2003-2018.
    J Hypertens. 2023;41:1713-1720.
    >> Share

  609. SCHMIDT-LAUBER C, Alba Schmidt E, Hanzelmann S, Petersen EL, et al
    Increased blood pressure after nonsevere COVID-19.
    J Hypertens. 2023;41:1721-1729.
    >> Share

  610. LEE SH, Lee CJ, Kang Y, Park JM, et al
    A randomized trial of genotype-guided perindopril use.
    J Hypertens. 2023;41:1768-1774.
    >> Share

  611. WIERSINGA JHI, Rhodius-Meester HFM, Wolters FJ, Trappenburg MC, et al
    Orthostatic hypotension and its association with cerebral small vessel disease in a memory clinic population.
    J Hypertens. 2023;41:1738-1744.
    >> Share


  612. Skin NA+, K+ and water before and after surgical cure of human primary aldosteronism: Erratum.
    J Hypertens. 2023;41:1869.
    >> Share

  613. FENG L, Ye Z, Mo C, Wang J, et al
    Elevated blood pressure accelerates white matter brain aging among late middle-aged women: a Mendelian Randomization study in the UK Biobank.
    J Hypertens. 2023;41:1811-1820.
    >> Share

  614. ZHANG X, Zhou Y, Yang J, Wang Y, et al
    Trend of blood pressure changes among children from 2012 to 2022: findings from student health surveillance in Eastern China.
    J Hypertens. 2023;41:1821-1830.
    >> Share

  615. YOUNIS D, Mosbah A, Zakaria MM, Awadalla A, et al
    Urinary congophilia in pregnancy: a marker of kidney injury rather than preeclampsia.
    J Hypertens. 2023;41:1760-1767.
    >> Share

    October 2023
  616. ZAHNER MR, Brown MC, Chandley MJ
    Inactivation of the paraventricular nucleus attenuates the cardiogenic sympathetic afferent reflex in the spontaneously hypertensive rat.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003542.
    >> Share

  617. GHAZI L, Cohen JB, Townsend RR, Drawz PE, et al
    Orthostatic hypotension, orthostatic hypertension, and ambulatory blood pressure in patients with chronic kidney disease in CRIC.
    J Hypertens. 2023 Oct 27. doi: 10.1097/HJH.0000000000003604.
    >> Share

  618. MA H, Wang C, Jiang M, Jin K, et al
    Persistently elevated sFlt-1 and recovery of reduced ADAMTS13 activity in malignant hypertension.
    J Hypertens. 2023 Oct 23. doi: 10.1097/HJH.0000000000003601.
    >> Share

  619. KASANAGOTTU K, Mukamal KJ, Landon BE
    Predictors of treatment intensification in uncontrolled hypertension.
    J Hypertens. 2023 Oct 20. doi: 10.1097/HJH.0000000000003598.
    >> Share

  620. SASAKI N, Ueno Y, Ozono R, Yoshimura K, et al
    Association of serum uric acid levels with blood pressure and the incidence of hypertension in the middle-aged and elderly populations.
    J Hypertens. 2023 Oct 12. doi: 10.1097/HJH.0000000000003597.
    >> Share

  621. ARAUJO-CASTRO M, Garcia Sanz I, Minguez Ojeda C, Hanzu F, et al
    Risk factors for intraoperative hypertensive crisis in patients with pheochromocytomas and sympathetic paragangliomas.
    J Hypertens. 2023 Oct 11. doi: 10.1097/HJH.0000000000003596.
    >> Share

  622. MANCIA G, Facchetti R, Quarti-Trevano F, Dell'Oro R, et al
    Comparison between visit-to-visit office and 24-h blood pressure variability in treated hypertensive patients.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003582.
    >> Share

  623. LI M, Qu K, Wang Y, Wang Y, et al
    Associations of hypertensive disorders of pregnancy with cognition, dementia, and brain structure: a Mendelian randomization study.
    J Hypertens. 2023 Oct 10. doi: 10.1097/HJH.0000000000003593.
    >> Share

  624. PEETERS LEJ, Kappers MHW, Hesselink DA, van der Net JB, et al
    Antihypertensive drug concentration measurement combined with personalized feedback in resistant hypertension: a randomized controlled trial.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003585.
    >> Share

  625. RIJAL A, Adhikari TB, Dhakal S, Maagaard M, et al
    Effects of adding exercise to usual care on blood pressure in patients with hypertension, type 2 diabetes, or cardiovascular disease: a systematic review with meta-analysis and trial sequential analysis.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003589.
    >> Share

  626. BROSOLO G, Da Porto A, Bulfone L, Vacca A, et al
    Cortisol secretion and abnormalities of glucose metabolism in nondiabetic patients with hypertension.
    J Hypertens. 2023 Oct 6. doi: 10.1097/HJH.0000000000003590.
    >> Share

  627. BASTA K, Ledwaba-Chapman L, Dodhia H, Ashworth M, et al
    Hypertension prevalence, coding and control in an urban primary care setting in the UK between 2014 and 2021.
    J Hypertens. 2023 Oct 2. doi: 10.1097/HJH.0000000000003584.
    >> Share

    September 2023
  628. DE LA SIERRA A, Ruilope LM, Martinez-Camblor P, Vinyoles E, et al
    Impact of timing of antihypertensive treatment on mortality: an observational study from the Spanish Ambulatory Blood Pressure Monitoring Registry.
    J Hypertens. 2023 Sep 27. doi: 10.1097/HJH.0000000000003581.
    >> Share

  629. DUTRA RT, Bensenor IM, Goulart AC, Pereira AC, et al
    Carotid intima-media thickness and incident hypertension: the Brazilian Longitudinal Study of Adult Health.
    J Hypertens. 2023 Sep 19. doi: 10.1097/HJH.0000000000003567.
    >> Share

  630. OHARA H, Takeuchi F, Kato N, Nabika T, et al
    Genotypes of Stim1 and the proximal region on chromosome 1 exert opposite effects on stroke susceptibility in stroke-prone spontaneously hypertensive rat.
    J Hypertens. 2023 Sep 15. doi: 10.1097/HJH.0000000000003566.
    >> Share

  631. RIVASI G, Ceolin L, Turrin G, Tortu' V, et al
    Prevalence and correlates of frailty in older hypertensive outpatients according to different tools: the HYPER-FRAIL pilot study.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003559.
    >> Share

  632. BOS-ROUBOS AG, Wingbermuhle E, Giesen M, Kersseboom R, et al
    Hypertension with hidden causes: the cognitive and behavioral profile of an adult female with chronic stress and 16p11.2 microdeletion.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003565.
    >> Share

  633. SHI Y, Zhou W
    Threshold effect of systemic immune inflammatory index on hypertension in American adults (NHANES 2017-2020).
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003560.
    >> Share

  634. CHARCHAR FJ, Prestes PR, Mills C, Ching SM, et al
    Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension.
    J Hypertens. 2023 Sep 13. doi: 10.1097/HJH.0000000000003563.
    >> Share

  635. MA G, Li J, Xie J, Li Y, et al
    Pulse pressure and its association with body composition among Chinese men and women without diagnosed hypertension: the China Kadoorie Biobank.
    J Hypertens. 2023 Sep 7. doi: 10.1097/HJH.0000000000003549.
    >> Share

  636. TROPEA T, Mavichak W, Evangelinos A, Brennan-Richardson C, et al
    Fetoplacental vascular effects of maternal adrenergic antihypertensive and cardioprotective medications in pregnancy.
    J Hypertens. 2023 Sep 1. doi: 10.1097/HJH.0000000000003532.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016